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Quantitative Optical Imaging Platform for Studying
Neurovascular Hemodynamics During Ischemic Stroke
Colin Tan Sullender, Ph.D.
The University of Texas at Austin, 2018
Supervisor: Andrew K. Dunn
The measurement of cerebral hemodynamics is vital for the study of
physiological and pathophysiological conditions in the brain. Preclinical re-
search examining the mechanisms, outcomes, and efficacies of interventions
during ischemic stroke require quantitative imaging technologies. This disserta-
tion presents the development of an optical imaging platform capable of chronic
in vivo monitoring of cortical hemodynamics during ischemic stroke and the
subsequent recovery. The system combines two different imaging techniques,
laser speckle contrast imaging (LSCI) and oxygen-dependent quenching of
phosphorescence, to measure cerebral blood flow (CBF) and dissolved oxygen
tension (pO2) within cortical vasculature. Phosphorescence signal localization
is achieved through the use of a spatial light modulator to selectively pattern
excitation light in order to overcome the traditional limitations of the imaging
modality. The spatial light modulator is also utilized to perform artery-targeted
photothrombosis for the induction of highly-localized, reproducible infarcts
vii
as an extension of the photothrombotic model of ischemic stroke. The LSCI
hardware implements the multi-exposure speckle imaging (MESI) technique
for robust estimates of CBF that facilitate day-to-day and between-subject
comparisons. The integration of an awake imaging system eliminates the con-
founding effects of anesthesia upon cerebral hemodynamics. The capabilities
of the complete optical imaging platform are demonstrated by monitoring the
acute hemodynamic response during targeted photothrombosis and the chronic
recovery of the resulting ischemic infarct.
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Chapter 1
Introduction
Cerebrovascular diseases such as stroke are the fifth leading cause of
death in the United States and the primary cause of chronic adult disability
in the Western world [1]. Almost 800,000 people in the United States suffer a
stroke each year with an estimated total medical cost of over $40 billion [2].
Ischemic strokes represent approximately 87% of all cases and occur when blood
flow to the brain is disrupted by the formation of a thrombosis or embolism.
While less prevalent, hemorrhagic strokes are associated with higher mortality
rates [3] and occur when an aneurysm or blood vessel ruptures in the brain.
Patients who seek treatment within the first few hours of symptom onset
have drastically improved outcomes compared to those who receive delayed
care [4]. The only FDA-approved pharmaceutical treatment for an ischemic
stroke is recombinant tissue plasminogen activator (tPA), which enzymatically
dissolves blood clots after being administered intravenously. However, only
about 7% of ischemic stroke patients ever receive the treatment, because it
must be administered within the first three hours after the onset of symptoms
[5]. Unless the patient qualifies for a catheter-based mechanical thrombectomy
[6], there are very few treatment options once the time window for tPA has
passed. Chronic management relies upon pharmaceutical prophylaxis with
1
anticoagulants, antihypertensives, and antihyperlipidemic statins, similar to
that of other cardiovascular diseases [7, 8, 9]. Physical rehabilitation is often
prescribed to help patients improve functional activity through residual neu-
roplasticity with varying degrees of efficacy [10, 11, 12, 13]. Current research
predominantly focuses on the development of new therapeutics targeting the
circulatory and nervous systems through pharmacological, surgical, or behav-
ioral interventions. These preclinical studies have a vital need for quantitative
hemodynamic measurements to evaluate the efficacy of interventions in disease
models of ischemic stroke.
Focal ischemic stroke is characterized by a localized reduction in blood
flow to part of the brain following thrombotic or embolic occlusion of a blood
vessel. The loss of blood supply rapidly triggers the ischemic cascade, a series of
biochemical events that ultimately cause irreversible tissue damage and neuronal
death [14]. The region with the most severe reduction in blood flow is termed
the “ischemic core” and can experience cellular death within minutes following
the occlusion. Surrounding the core is the “ischemic penumbra,” a region of
moderate to minimal ischemia supported by residual perfusion from collateral
blood supply. Cellular death proceeds much more slowly in this metastable
region as the infarct slowly expands into the penumbra over time [15, 16]. This
has made the penumbra the primary target for neuroprotective interventions
in an attempt to improve tissue viability and restrict the expansion of the core
[17, 18]. Understanding the hemodynamic mechanisms and metabolic burdens
that affect the evolution of the ischemic penumbra is vital to improving the
2
efficacy of stroke treatments.
1.1 Imaging of Hemodynamics in the Brain
Modern medical imaging technology has revolutionized our ability to
diagnose and treat pathologies in the human body. Many of these same
techniques have also played a critical role in our fundamental understanding
of the anatomy and physiology of the brain. Optical imaging modalities have
been used extensively [19] to study the hemodynamics of phenomena such
as neurovascular coupling [20] and diseases such as stroke [21], epilepsy [22],
migraines [23], and Alzheimer’s [24]. However, optical imaging has limited
clinical translation because of difficulties in delivering light through the thick,
highly-scattering skull. Human hemodynamic studies typically rely upon well-
established medical imaging technologies such as magnetic resonance imaging
and positron-emission tomography.
1.1.1 Non-Optical Methods
The primary clinical technique for studying hemodynamic changes in
the brain is magnetic resonance imaging (MRI) [25]. MRI has the ability to
observe both anatomical structure and localize functional dynamics without
the need for exogenous contrast agents. Functional MRI (fMRI) depends
upon blood-oxygen-level dependent (BOLD) contrast, which can detect relative
changes in the concentration of deoxyhemoglobin, a strongly paramagnetic
molecule [26]. The BOLD hemodynamic response reveals localized recruitment
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of oxygen via neurovascular coupling and gives fMRI the ability to measure the
cerebral metabolic rate of oxygen consumption (CMRO2), a metric correlated
with brain activity. It also provides an indirect measure of cerebral blood
flow (CBF) because CMRO2 is dependent upon regional perfusion. However,
fMRI suffers from poor spatial and temporal resolutions, prohibiting it from
examining neurovascular structure or hemodynamics in fine detail [26].
Positron-emission tomography (PET) offers functional localization with
high sensitivity at similar resolutions to fMRI but requires the injection or
inhalation of a radioactive tracer [27]. CBF and CMRO2 can be measured
using isotopes of oxygen gas or carbon dioxide while the cerebral metabolic
rate of glucose consumption (CMRGlc), another proxy for brain activity, can
be measured using 18F fluorodeoxyglucose (FDG). PET requires access to
cyclotron-produced radiopharmaceuticals and the instrumentation is rarely
found outside of medical facilities. Radiation exposure also limits the number
of successive imaging sessions that can be conducted in a subject.
Transcranial Doppler ultrasound offers measurements of CBF velocity in
large arteries and veins and is an increasingly popular diagnostic and therapeutic
monitoring tool [28]. Combined with anatomical information to obtain vessel
size, the velocity measurements can be converted to volumetric flow. Clinically,
the technique is limited to diagnosing global or hemispheric hypoperfusion
because measurements are constrained to only the largest vessels [29]. However,
the temporal resolution is significantly higher than fMRI or PET, which allows
for dynamic monitoring of blood flow velocity over time.
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1.1.2 Optical Methods
Optical imaging offers significantly higher spatial and temporal resolu-
tions but with limited depth penetration compared to non-optical techniques.
The increased resolution has facilitated the study of microscale brain hemody-
namics and the complex relationship between neural activity and blood flow.
However, spatial resolution is highly dependent upon gaining optical access to
the area of interest, especially when imaging through highly-scattering tissues
such as the skull. In animal models, the surgical implantation of optically-clear
cranial windows is a common method to gain direct optical access to the surface
of the brain.
Pulse oximetry to measure peripheral oxygen saturation (SO2) is the
most common clinical application of optical hemodynamic imaging. The non-
invasive spectroscopic technique is based on absorption differences between
oxygenated and deoxygenated hemoglobin and therefore requires no exogenous
contrast agents. Transcranial near-infrared spectroscopy (NIRS) is a related
technique that has been applied to visualizing functional [30] and ischemic
[31] cerebral hemodynamics in humans. While it has limited clinical imple-
mentations [32], results from NIRS have been strongly correlated with fMRI
measurements in stroke patients [33].
Hemoglobin has also been targeted as an endogenous contrast agent
for optical intrinsic signal (OIS) imaging or multispectral reflectance imaging.
These camera-based approaches measure changes in the reflectance of tissue at
multiple wavelengths in order to estimate relative chromophore concentrations
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[34]. The resulting changes in oxy- and deoxyhemoglobin in response to stimuli
are analogous to BOLD contrast from fMRI. OIS imaging has been performed
during external stimulation to study the functional organization of the cortex
at resolutions much greater than fMRI [35, 36]. Multispectral imaging has been
combined with CBF estimates from laser speckle contrast imaging to measure
the metabolic response to focal ischemia [37].
Optical imaging can directly measure flow velocities within blood vessels
by tracking or labeling erythrocytes. High frame rate cameras can be used for
reflectance imaging of hemoglobin within cortical surface vasculature in order
to follow erythrocyte motion [38]. Alternatively, laser scanning microscopy of
fluorescent contrast agents can be used to measure erythrocyte velocity within
subsurface microvasculature [39]. Newer imaging techniques such as optical
coherence tomography (OCT) now allow for cross-sectional, depth-resolved
measurements of blood flow and hemoglobin concentrations [40].
1.2 Measuring Blood Flow with Dynamic Light Scatter-
ing
The monitoring of in vivo blood flow dynamics is invaluable in both
clinical and laboratory environments for understanding numerous physiological
and pathophysiological phenomena. Angiographic techniques and ultrasound
have garnered widespread adoption in clinics for providing anatomical and
hemodynamic information. Optical imaging using dynamic light scattering
(DLS) has become increasingly popular in preclinical research for measuring
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perfusion and has begun translating to clinical applications. The most common
DLS techniques are laser Doppler flowmetry and laser speckle contrast imaging
[41, 42]. These two modalities are different strategies for imaging the same
underlying physical phenomenon and are inherently based upon Doppler shifts
in the frequency of coherent light caused by particle motion.
1.2.1 Laser Doppler Flowmetry
Laser Doppler flowmetry (LDF) relies upon the frequency spectrum
analysis of backscattered coherent light to measure relative perfusion [41]. While
it offers high temporal resolution, LDF is typically limited to measurements
at a single spatial location. The introduction of scanning mirrors allow for
spatially-resolved measurements at the expense of speed, with low-resolution
(256 x 256 pixels) acquisitions taking several minutes in commercially available
systems [43]. Full-field laser Doppler imaging (LDI) offers higher resolutions
(480 x 480 pixels) at significantly faster speeds (14 frames per second) but relies
upon expensive high frame rate cameras and complex acquisition hardware
[44]. LDF is frequently used as the “gold standard” during the development of
newer DLS flowmetry techniques.
1.2.2 Laser Speckle Contrast Imaging
Laser speckle contrast imaging (LSCI) is a full-field optical imaging
technique that provides instantaneous maps of blood flow by imaging time-
varying laser speckle. The technique was first demonstrated by Fercher and
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Briers in 1981 using single-exposure photography of retinal blood flow [45].
Because images were captured on film and required development prior to
processing, the earliest LSCI instruments suffered from very low temporal
resolutions and large uncertainties. The arrival of commercially available
CCD cameras and faster computers in the 1990s allowed for near real-time
LSCI perfusion measurements in the skin [46, 47]. The technique was first
applied to imaging CBF dynamics in rodents in 2001 [48] and has since seen
widespread adoption by the neuroscience community for animal studies on
stroke [49, 50, 51], spreading depression [52, 53], and functional activation
[54, 55]. LSCI has also seen clinical translation as an intraoperative tool for
monitoring blood flow and perfusion during brain surgery [56, 57].
1.2.2.1 Theory
Laser speckle is the random interference pattern produced when coherent
light scatters from a rough surface or inhomogeneous medium. It manifests
because scattered photons travel slightly different path lengths, resulting in
constructive and destructive interference between the out of phase coherent
light waves. Imaging this scattered light produces a random two-dimensional
interference pattern on the detector known as subjective speckle [58]. If the
sample contains scattering particles in motion, such as erythrocytes flowing
through vasculature, the speckle pattern will fluctuate temporally. Imaging
a time-varying speckle pattern results in the integration of these temporal
intensity fluctuations over the camera’s exposure time. Assuming the exposure
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time is longer than the time scale of the speckle intensity fluctuations (<1
ms for biological tissues), the resulting speckle pattern will be blurred by the
integration. Regions with greater motion will experience more rapid intensity
fluctuations and therefore more blurring of the imaged speckle pattern. Because
the dynamics of the speckle pattern encodes information about the underlying
particle motion, a measure of flow can be obtained by quantifying the spatial
blurring. This requires calculating the local speckle contrast (K), which is
defined as the ratio between the standard deviation (σs) and the mean intensity
of pixel values (〈I〉) within a small region of the image at a single exposure
time (T ) [47].
K(T ) =
σs(T )
〈I〉 (1.1)
A full speckle contrast image is obtained by computing Equation 1.1
within an N x N sliding window at every pixel of the raw image. The window
size must be chosen carefully to ensure an accurate estimate of local contrast
while maintaining adequate spatial resolution in the resulting image. Statistical
analysis [59] and past precedent [42] have established N = 7 as an optimal
window size and it is used exclusively throughout this dissertation. A properly
sampled [60] speckle pattern will produce speckle contrast values ranging
between 0 and 1 [61]. When K = 1, there is no blurring of the speckle pattern
and therefore no discernible motion in the sample during the camera exposure.
However, when K = 0, the scattering particles are moving sufficiently fast to
average out all the speckles.
An example of the raw intensity image of the speckle pattern and
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Figure 1.1: (A) Traditional LSCI microscope system consisting of an illumi-
nating laser, imaging optics, and a camera. (B) Raw intensity image of the
speckle pattern and the resulting speckle contrast image from vasculature in
the mouse cerebral cortex. Regions of high contrast in the intensity image
(blue) have low flow compared to regions with low contrast (orange), which
have high flow.
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corresponding computed speckle contrast image are shown in Figure 1.1B.
The imagery was obtained in vivo from the cerebral cortex of a mouse under
general anesthesia. The graininess of the speckle pattern can be seen in the raw
intensity image, with some regions appearing more blurred than others. The
speckle contrast image was computed directly from the intensity image using
Equation 1.1 to generate a two-dimensional map of motion for the field-of-view.
Within the cortex, erythrocytes are the primary moving scattering particles
and therefore vasculature is highlighted by the speckle contrast image. Regions
of higher flow, such as a large vessel, experience more blurring of the speckle
pattern and therefore have lower K values. Conversely, regions of low flow,
such as the space between resolvable surface vessels (parenchyma), experience
less blurring and therefore have higher K values. Measurements within the
parenchyma sample the slower, more isotropic blood flow of unresolvable
microvasculature beneath the surface of the cortex.
The shallow depth penetration of LSCI is a significant limitation of
the imaging technique. Detected photons only sample a few hundred microns
of superficial tissue without any depth resolution and are heavily-weighted
towards large surface vasculature [62]. While skin and retinal imaging can
be performed directly on the tissue of interest, CBF imaging requires either
thinning or removing the skull to gain optical access [61].
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1.2.2.2 Instrumentation
The simple instrumentation necessary to perform LSCI has contributed
to its popularity as a blood flow imaging technique. A basic LSCI microscope
consists of an illuminating laser, imaging optics, and a camera (Figure 1.1A).
The laser output is expanded to broadly epi-illuminate the area of interest at a
normal to oblique angle depending on the application. Red to near-infrared
laser diodes (600-850 nm) are typically used to take advantage of the tissue
optical window where scattering dominates absorption by hemoglobin or water.
Because LSCI is based entirely upon scattering, wavelength is less important
than other imaging techniques that rely upon absorption. However, the coher-
ence length of the laser dictates the longest possible path length through the
tissue that can be properly sampled for quantitative flow information. Lasers
with narrow spectral bandwidths (e.g. single longitudinal mode or narrow
linewidth lasers) offer coherence lengths of several meters and are more than
sufficient for use in LSCI.
Camera selection varies broadly in literature and generally any charge-
coupled device (CCD) or complementary metal-oxide-semiconductor (CMOS)
camera is appropriate for use with LSCI [63, 61]. Even cheap cameras such as
webcams have been shown to provide reliable blood flow imagery [64]. While
spectral sensitivity, bit depth, pixel size, frame rate, and noise are all important
factors to consider, most researchers use the cameras readily available in their
laboratories. However, it is critical that the speckle pattern is properly sampled
such that the speckle size is at least twice the size of a single camera pixel [60].
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Deviation from the spatial Nyquist sampling criterion will reduce contrast and
decrease the variation in the speckle contrast image.
1.2.2.3 Quantitative Accuracy
Speckle contrast values are only indicative of the amount of motion
in a sample and are not linearly proportional to particle speed or volumetric
flow. Understanding the nonlinear relationship with the complex underlying
blood flow is an active area of research in the DLS field [65, 66]. Quantitative
flow measurements require accurately relating the speckle contrast value to
the characteristic decay time (τc) of the speckle autocorrelation function. DLS
theory has established that the speckle autocorrelation time is inversely pro-
portional to the speed of the scatters in the single scattering regime [67] and
weighted by the number of dynamic scattering events under multiple scattering
[68, 38, 69]. Since Fercher and Briers first proposed a simple model relating K
and τc [45], there have been numerous improvements to more robustly extract
the flow contributions from the observed speckle [70, 71]. The model described
by Bandyopadhyay et al. [70] relates the measured K with τc:
K(T, τc) =
(
β
e−2x − 1 + 2x
2x2
)1/2
(1.2)
where x = T/τc, T is the camera exposure time, and β is a normalization factor
that accounts for speckle averaging due to the mismatch between speckle size
and pixel size, polarization, and the finite coherence length of the laser [72].
β is frequently assumed to be equal to 1, limiting the technique to relative
measures of flow. This model assumes that detected photons only experience
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single scattering interactions and that the underlying particle motion has a
Lorentzian velocity distribution. Despite these assumptions, Equation 1.2 has
been used extensively to relate measured speckle contrast with relative blood
flow [42, 61] and will be used throughout this dissertation.
The inverse correlation time (ICT) is frequently interpreted as being
proportional to the speed of the moving particles (1/τc ∝ νscatterers) based on
assumptions from laser Doppler flowmetry [67]. While highly dependent upon
the optical properties and flow conditions of the sample, ICT values in single
vessels correspond to the speed of the flowing erythrocytes. In parenchyma
regions, ICT is a measure of local perfusion because flow cannot be isolated to
individual vessels from the depth integrated contributions of the unresolvable
microvasculature [55, 42]. Despite these assumptions and limitations, multiple
studies have demonstrated strong correlations between LSCI estimates of
CBF and absolute measurements from other perfusion indices [49, 50, 38].
The development of multi-exposure speckle imaging [71] has improved the
quantitative accuracy of the LSCI technique and will be discussed extensively
in Chapter 4.
1.3 Measuring Oxygen Tension In Vivo
In vivo measurements of molecular oxygen have historically been made
using highly invasive Clarke electrodes that are limited to point measurements
outside the vascular lumen [73, 74, 75]. While targets as small as a few
microns can be measured with the appropriate electrode, there are significant
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tradeoffs between the signal-to-noise ratio and spatial specificity depending
on probe size. Electrodes can also only approximate intravascular oxygen
concentrations through measurements in nearby interstitial tissue. Magnetic
resonance techniques allow for noninvasive imaging of hemoglobin saturation,
but suffer from low spatial resolutions and can only be correlated with free
oxygen levels in the blood [75, 76, 77, 78]. Oxygen-sensitive porphyrin probes
allow for noninvasive, highly sensitive optical oxygenation measurements based
on phosphorescence quenching [79]. While an injection of the probe is required,
absolute oxygen tension (pO2) can be directly calculated from the lifetime of
the measured phosphorescence decay.
1.3.1 Oxygen-Dependent Quenching of Phosphorescence
Recent advances in oxygen-sensitive probe design have made oxygen-
dependent quenching of phosphorescence a powerful tool for in vivo measure-
ments of pO2 within both intravascular and interstitial spaces [79, 80]. This
method relies upon dissolved environmental oxygen quenching the phospho-
rescence of porphyrin dyes or ruthenium complexes, which causes a change
in excited state lifetime (Figure 1.2A). The pO2 can be quantified from the
measured lifetime (Appendix A) using the Stern-Volmer relationship:
τ0
τ
= 1 + kqτ0[pO2] (1.3)
where τ is the measured phosphorescence lifetime, τ0 is the unquenched lifetime,
and kq is a probe-specific quenching rate constant that depends upon the local
environment (temperature, pH, atmospheric pressure, and salinity). Equation
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Figure 1.2: (A) Jablonski diagram of phosphorescence quenching by environ-
mental molecular oxygen. (B) Phosphorescence quenching causes a reduction
in the measured lifetime and is dependent upon [O2] or pO2.
1.3 allows for the absolute pO2 to be obtained from the measured phosphores-
cence lifetime provided kq and τ0 are well-characterized under physiological
conditions. Furthermore, because lifetime measurements are independent of
absolute intensity, they can easily be isolated from other chromophores and
tissue scattering, making them ideal for integration into multi-modal imaging
systems.
The phosphorescence lifetime can be measured in the time domain
by exciting the probe with a short pulse of light and collecting the emitted
phosphorescence. The resulting phosphorescent decay curve can then be fit to
an exponential to obtain the phosphorescence lifetime (τ):
I(t) = A+Be−t/τ (1.4)
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Alternatively, frequency domain measurements can be made by calcu-
lating the phase shift or demodulation of the phosphorescence generated by
sinusoidally-modulated light. While excitation light is utilized more efficiently
in frequency domain measurements, they are more difficult to implement and
process than time domain measurements.
Point detectors such as avalanche photodiodes or photomultiplier tubes
are commonly used to acquire the phosphorescent decays because of their high
sensitivity, gain, and temporal resolutions. However, these detectors limit the
lifetime measurements to single spatial locations unless laser scanning systems
[81, 82] or intensified exposure-gated cameras [83, 84] are utilized. Despite
these limitations, in vivo measurements of oxygen-dependent quenching of
phosphorescence have been conducted in a variety of tissues including the
retina, brain, muscle, and peritoneum [73]. The technique has also been used
extensively to study cortical oxygenation, often in conjunction with other
imaging modalities [85, 86].
1.4 Research Overview
The overall goal of this project is the development of an optical imaging
platform capable of the chronic monitoring of cortical hemodynamics during
ischemic stroke and the subsequent recovery. The system combines two different
imaging techniques, LSCI and oxygen-dependent quenching of phosphorescence,
to measure CBF and pO2 within cortical vasculature. The development of the
imaging system has four iterative milestones, each extending the capabilities
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of the platform. Chapter 2 details the initial design and construction of the
dual-modality system and demonstrates acute in vivo measurements in mice.
Chapter 3 describes modifications to the system to perform artery-targeted
photothrombosis, an extension of the conventional photothrombotic model of
ischemic stroke. The technique is demonstrated in vivo with the acute and
chronic hemodynamics monitored using the imaging platform. The functional
effects of the targeted infarct on fine motor skills are also examined. Chapter 4
details the implementation of multi-exposure speckle imaging to improve the
robustness of chronic CBF measurements. Finally, Chapter 5 describes the
transition to awake animal imaging and demonstrates chronic imaging of the
recovery from targeted photothrombotic stroke.
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Chapter 2
Simultaneous Imaging of Cerebral Blood Flow
and Oxygen Tension
Measurements of hemodynamic parameters in cerebral vasculature have
been invaluable in preclinical research for understanding the physiology of
the normal and diseased brain. The combination of imaging techniques to
simultaneously measure multiple hemodynamic parameters has become increas-
ingly common and used to study stroke [37], cortical spreading depression [84],
and functional brain activation [54, 87]. Advancements in computer process-
ing power and the increased availability of lasers and light-emitting diodes
across a diverse range of wavelengths have facilitated the development of these
multi-parameter hemodynamic imaging platforms.
In 2010, Ponticorvo and Dunn [88] detailed a dual-modality imaging
system capable of simultaneously measuring cerebral blood flow (CBF) and
oxygen tension (pO2) in cortical vasculature. The system combined laser speckle
contrast imaging (LSCI) and oxygen-dependent quenching of phosphorescence.
An unpublished modification to the system added multispectral reflectance
imaging for measurements of oxy- and deoxyhemoglobin [89]. The primary
innovation of this design was the use of a digital micromirror device (DMD) to
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achieve spatial localization of the phosphorescent signal. A DMD is an optical
semiconductor device that consists of a two-dimensional array of thousands
of individually addressable mirrors that can be tilted to spatially modulate
light. By patterning excitation light, phosphorescence could be constrained to
only the targeted regions of interest, which allowed the use of high sensitivity
point detectors. This overcame the traditional limitations of spatially-resolved
phosphorescence imaging that either required the use of expensive laser scanning
systems [81, 82] or exposure-gated intensified cameras [83, 84].
However, a major limitation of this system was the phosphorescent probe
Oxyphor R2 [90], which required conjugation with albumin in order to remain
stable in vivo. The system was also optically limited to only targeting large
regions of the field of view (FOV) for pO2 measurements and was incapable
of performing multiple actions simultaneously with the DMD. This chapter
details a redesign of the system by Ponticorvo and Dunn [88] with the goal
of improving the spatial and temporal resolutions of both imaging modalities
through implementation of newer hardware and a more robust oxygen-sensitive
phosphorescent probe. The new imaging system was described in a methods
paper1 published in Neurophotonics [91].
1Portions of this chapter and the next were adapted from ‘C. Sullender, A. Mark, T.
Clark, T. Esipova, S. Vinogradov, T. Jones, and A. Dunn. Imaging of cortical oxygen tension
and blood flow following targeted photothrombotic stroke. Neurophotonics, 5(3):035003,
July 2018.’ C.S. and A.M. developed and built the instrumentation. C.S. performed the
experiments, analyzed the results, and wrote the manuscript. T.C. performed the cranial
window implantation surgery. T.E. and S.V. developed and provided the phosphorescent
probe. T.J. and A.D. supervised the project. All authors contributed to manuscript revisions.
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Figure 2.1: (A) Excitation and emission spectra for Oxyphor PtG4. (B)
Calibration curve relating environmental pO2 to the measured phosphorescence
lifetime (τ) under physiological conditions (37 ◦C, pH 7.2).
2.1 Instrumentation
The following dual-modality imaging system combines LSCI with oxygen-
dependent quenching of phosphorescence for the simultaneous measurement
of CBF and pO2. Because LSCI is rarely light-limited, the optical design is
focused on the projection of patterned excitation light off the DMD and the
efficient collection of the emitted phosphorescence. The spectral cutoffs for the
system were dictated by the new phosphorescent probe, Oxyphor PtG4 [80],
an oxygen-sensitive dendritic probe that contains Platinum(II)-meso-tetra-(3,5-
dicarboxyphenyl)tetrabenzoporphyrin (PtTBP) as the phosphorescent core.
Unlike its predecessors Oxyphor R2 and G2 [90], which were limited
to albumin-rich environments for stability, Oxyphor PtG4 is encapsulated
within a hydrophobic dendrimer and PEGylated to increase solubility and
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biocompatibility. These modifications provide increased stability across a wider
range of temperatures and pH values and eliminate the need for conjugation
with blood proteins [80]. Oxyphor PtG4 has two excitation maxima near 435
nm (Soret) and 623 nm (Q band) and a broad emission spectra peaking at 782
nm (Figure 2.1A). The probe was calibrated under physiological conditions
(37 ◦C, pH 7.2) by measuring the phosphorescent decay lifetime (τ) as the
environmental pO2 was increased from 0 mmHg to 160 mmHg (Figure 2.1B).
The unquenched lifetime (τ0) is 47 µs in an oxygen-free environment.
2.1.1 Optical System
The schematic of the optical system can be seen in Figure 2.2. The
excitation and emission spectra of Oxyphor PtG4 dictated laser selection and
dichroic beamsplitter cutoff wavelengths. LSCI was performed using a 685 nm
laser diode (50 mW, HL6750MG, Thorlabs, Inc.) illuminating the sample at
an oblique angle. The laser was mounted in a temperature-controlled housing
(TCLDM9, Thorlabs, Inc.) and collimated with a slight divergence using an
aspheric lens (C240TME-B, Thorlabs, Inc.) to illuminate the entire FOV. The
operating current was set using a laser diode controller (LDC202, Thorlabs,
Inc.) and the diode temperature regulated using a temperature controller
(TED200C, Thorlabs, Inc.). The scattered light was relayed through a pair of
dichroic beamsplitters and a bandpass filter (685±40 nm, S685/40m, Chroma
Technology Corp.) to an NIR-enhanced CMOS camera (acA1300-60gmNIR,
1280 x 1024 pixels, Basler AG) with 2x magnification for a FOV of 3.5 x 2.8
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Figure 2.2: Schematic of the dual-modality imaging system combining LSCI
with oxygen-dependent quenching of phosphorescence.
mm. The camera was controlled via the Pylon API (Basler AG) using custom
software written in C++ (i.e. the “Speckle Software”).
Separately, two different lasers at 445 nm and 637 nm were selected to
target the Soret and Q band excitation maxima of Oxyphor PtG4. Each laser
can be used independently to collect phosphorescence lifetime measurements
with different penetration depths and sample volumes because of their wave-
lengths. The 445 nm laser (200 mW, AixiZ LLC) is a packaged device with
a 4 mm collimated output that operates at a fixed current with convection
cooling. The beam size was reduced to 1 mm and gated using an 80 MHz
acousto-optic modulator (23080-2-LTD AOM and 21080-1AM RF Driver, Neos
Technologies, Inc.). The 637 nm laser diode (250 mW, HL6388MG, Thorlabs,
Inc.) was mounted in a temperature-controlled housing (LDM21, Thorlabs,
Inc.) and collimated using an aspheric lens (C330TME-B, Thorlabs, Inc.). The
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laser was directly gated using its driver (LDD400-1P, Wavelength Electronics,
Inc.) and the diode temperature regulated using an external temperature con-
troller (300B, Newport Corp.). Both lasers were gated via analog modulation
to produce 20 µs pulses of light for time domain phosphorescence lifetime
measurements.
The lasers were coaligned using a red hot mirror (580 nm cutoff, FM02,
Thorlabs, Inc.) and coupled into a fiber optic patch cord (P600-2-VIS-NIR,
Ocean Optics, Inc.) with a 600 µm core size. The modulated laser light was
relayed to the primary imaging system via the patch cord and re-collimated
to illuminate the DMD. A DLP® LightCrafter™ Evaluation Module (Texas
Instruments Inc.) was modified to expose the bare DMD (DLP3000, 608
x 684 pixels, 7.6 µm pitch, Texas Instruments Inc.) for illumination. The
spatially patterned modulated light was then relayed to the sample with 0.5x
magnification to selectively excite Oxyphor PtG4 for lifetime measurements.
The emitted phosphorescence was separated from the excitation and
scattered LSCI laser light using a pair of dichroic beamsplitters (650 nm,
ZT640rdc, Chroma Technology and 750 nm, FF750-SDi02, Semrock, Inc.)
and a bandpass filter (810±90 nm, ET810/90m, Chroma Technology Corp.)
and relayed to a photomultiplier tube for detection (H7422P-50, Hamamatsu
Photonics K.K.). Figure 2.3 contains an overview of the spectral separation in
the imaging system and Table 2.1 details each filter in the primary imaging
path.
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Figure 2.3: Dichroic beamsplitters and bandpass filters used to spectrally
separate light in the imaging system. A longpass dichroic beamsplitter (purple)
separates the excitation lasers (445 and 637 nm) from the scattered LSCI laser
(685 nm) and Oxyphor PtG4 phosphorescence emission (orange). A shortpass
dichroic beamsplitter (green) separates the LSCI light from the phosphorescence
for detection. Bandpass filters (shaded grey) limit ambient and scattered light
from reaching the detectors. All values are normalized.
Table 2.1: Summary of optical filters in the imaging system
Label Filter Usage Manufacturer Part Number
D1
650 nm longpass
dichroic beamsplitter
Excitation
Separation
Chroma ZT640rdc
D2
750 nm shortpass
dichroic beamsplitter
Emission
Separation
Semrock FF750-SDi02-25x36
D3 580 nm red hot mirror
Laser
Coalignment
Thorlabs FM02
F1
810±90 nm
bandpass
Phosphorescence
Isolation
Chroma ET810/90m
F2
685±40 nm
bandpass
LSCI
Isolation
Chroma S685/40m
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2.1.2 Acquisition Control
An overview of the control system can be seen in Figure 2.4. Both LSCI
and the phosphorescence lifetime measurements were performed simultaneously
using a single computer. The LSCI acquisition is controlled via the Speckle
Software, which implements the Pylon API (Basler AG) for comprehensive
control of the GigE camera. The Speckle Software allows for the real-time
calculation, display, and writing of speckle contrast imagery using an efficient
processing algorithm [92]. The camera was operated with a 5 ms exposure time,
which is standard for in vivo microvasculature studies using LSCI [93]. Raw
intensity images were acquired in bursts and saved at an effective 60 frames
per second (fps) at an 8-bit bit depth. The computed speckle contrast images
were saved as single-precision floating-point numbers and averaged together
(n = 45 frames) during post-processing for a final frame rate of 1.33 fps. A
standard LSCI acquisition produced data at a rate of 55 MB/s.
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The Speckle Software was also modified to control the DMD via its
Ethernet-over-USB command interface. Users can define arbitrarily-shaped
regions of interest (ROIs) using the LSCI camera as reference and upload
the resulting binary masks to the DMD for the patterning of excitation light.
Registration between the camera and the projected pattern can be performed
using the Speckle Software to guarantee alignment with the reference image (see
Section 2.1.4). Individual patterns or timed pattern sequences can be uploaded
and displayed on the DMD, with a TTL pulse emitted on each pattern change.
While the Speckle Software controls the patterning of excitation light for
the lifetime measurements, a separate LabVIEW (National Instruments Corp.)
program controls the waveform generation and phosphorescence decay acqui-
sition. A field-programmable gate array (FPGA) operating on a single-cycle
timed loop oversees digital-to-analog (DAC) and analog-to-digital (ADC) con-
version. The FlexRIO FPGA (PXIe-7965R, National Instruments Corp.) and
100 MHz transceiver module (NI-5781, National Instruments Corp.) reside in a
PXI chassis (PXIe-1082, National Instruments Corp.) with a high-bandwidth
embedded controller (PXIe-8130, National Instruments Corp.). The FPGA
communicates with the host computer over a 1 Gigabit Ethernet connection.
Waveform generation and acquisition occur simultaneously on the FPGA
with each complete cycle taking 32,768 ticks at the 100 MHz clock rate. Each
cycle is triggered upon DMD pattern change via TTL through an auxiliary
input on the transceiver. The excitation waveform contains a 20 µs square pulse
(2,000 ticks) for an overall 6% duty cycle and is output from the transceiver
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DAC between 0-1 V. Minimizing the pulse duration and duty cycle were
important because high excitation flux levels can produce damaging levels
of singlet oxygen [94]. If the 445 nm laser is being used, then the analog
signal is directed into the AOM. If the 637 nm laser is being used, then the
output is inverted and connected to the laser diode driver. The resulting
phosphorescence is detected by the PMT and amplified at a fixed 50 mV/µA
gain at 10 MHz (C9999, Hamamatsu Photonics K.K.). The analog signal is
digitized by the transceiver ADC with a 14-bit depth resolution. In order to
reduce the amount of data being saved, the FPGA accumulates the sum of n
cycles of phosphorescent decays before transferring to the host computer via a
direct memory access (DMA) first in, first out (FIFO) buffer. The LabVIEW
program writes the accumulated phosphorescent signal to a binary file (32-bit
integer) for post-processing. An optional setting enables on-the-fly fitting of the
phosphorescence decay curve for τ and estimates the pO2 using the Oxyphor
PtG4 calibration curve. However, this added computation can result in DMA
FIFO overflow at higher acquisition speeds.
Unlike LSCI, which operates at a fixed frame rate, the temporal resolu-
tion of the phosphorescence lifetime measurements is linearly dependent upon
the number of patterns being displayed on the DMD and the number of decays
accumulated on the FPGA. The digital controller on the DLP® LightCrafter™
can store 96 binary patterns on its internal memory buffer and operate at a
maximum pattern rate of 4000 Hz. The number of decays to accumulate on the
FPGA is ultimately determined by the strength of the phosphorescent signal,
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Table 2.2: Common acquisition settings for the phosphorescence lifetime mea-
surements (n = number of DMD patterns). Raw data is acquired by the FPGA
at a rate of 160 MB/s.
Pattern Rate
(Hz)
Decays Accumulated
(per Pattern)
Temporal
Resolution (s)
Host Data
Rate (KB/s)
1 2500 n 64
2 1250 n/2 128
10 250 n/10 640
50 50 n/50 3200
100 25 n/100 6400
which is influenced by the projected pattern size, Oxyphor PtG4 concentration,
and laser power. The amount of data transferred to the host computer is
inversely proportional to the number of records accumulated. Table 2.2 details
several acquisition settings for the phosphorescence lifetime measurements with
the 2 and 10 Hz pattern rates most commonly being utilized. While higher
pattern rates offer higher temporal resolutions, the reduced averaging of the
phosphorescent decays negatively affects the quality of the lifetime fitting.
A summary of the acquisition timing can be seen in Figure 2.5 with both
LSCI and the phosphorescence lifetime measurements operating simultaneously
but independently. This is possible because of the spectral separation of the
excitation and emission wavelengths (Figure 2.3). Both imaging modalities
share the same computer clock, so timestamps can easily be aligned during
post-processing.
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Figure 2.5: Acquisition timing paradigm for the LSCI and phosphorescence
lifetime measurements.
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2.1.2.1 Troubleshooting
During development of the phosphorescence lifetime measurement sys-
tem, two significant problems were encountered. The first was a severe band-
width limitation in the original preamplifier (SR570, Stanford Research Systems)
used to convert the current output from the PMT to a voltage signal for ADC.
The preamplifier was operated in high bandwidth mode with no filters active
and a gain of 50 mV/µA. This corresponds to a bandwidth between 200-800
kHz. The maximum possible bandwidth is 1 MHz and can only be achieved
at the lowest gain setting. This bandwidth is insufficient to properly sample
the phosphorescent decay curve at higher pO2 levels as τ grows exponentially
shorter (Figure 2.1B). The limitation was identified while performing measure-
ments under ambient conditions where pO2 > 150 mmHg. At this pO2 level, a
1 µs change in τ corresponds to over a 20 mmHg change in pO2. The problem
was resolved by transitioning to the higher bandwidth (10 MHz) preamplifier
detailed in Section 2.1.2. The >10x increase in bandwidth allows for proper
sampling of the entire physiologically-relevant portion of the Oxyphor PtG4
calibration curve.
The second issue was related to the clock settings for the single-cycle
timed loop on the FPGA. The PXIe-7965 FPGA module offers an onboard
40 MHz clock that was selected by default as the clock for the timed loop.
However, this requires crossing clock domains from the 100 MHz sample clock
on the NI-5781 transceiver to the onboard clock of the FPGA module. This
can result in data corruption because the FPGA can capture data as it is
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actively being updated at the higher sample rate. In order to safely cross clock
domains while guaranteeing data integrity, a FIFO buffer must be implemented.
Alternatively, the sample clock on the transceiver module can be used as the
clock for the single-cycle timed loop, which is how the issue was resolved on this
system. Operating at 100 MHz does result in oversampling our expected signal,
which is a problem that could be resolved by discarding unwanted samples.
2.1.3 DMD Alignment
Proper alignment and illumination of the DMD is critical for accurately
projecting the excitation light patterns. The DLP3000 DMD contains a 0.3-inch
diagonal micromirror array with 608 x 684 pixels arranged in a diamond con-
figuration with a ±12◦ tilt angle (Figure 2.6A). The DMD must be illuminated
at -24◦ from the normal for the specularly reflected light from mirrors in the
ON position to be directed along the desired optical axis (Figure 2.6B). Light
reflected from pixels in the OFF position will be directed +48◦ off axis and
can easily be blocked.
Because coherent light is being utilized, diffraction off the two-dimensional
(2D) micromirror array must be considered. The physics are analogous to that
of a 2D diffraction grating, except that two separate diffraction patterns will
be formed, each influenced by the two possible mirror positions (Figure 2.6C).
The position of the (0, 0) order and the intensity envelope follows the specular
reflection off the tilted mirror as described above. However, all other orders are
dependent upon incident angle, mirror pitch, mirror angle, and wavelength [95].
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Figure 2.6: (A) Mirrors are arranged in a diamond configuration on the DMD
with a 7.6 µm pitch and a ±12◦ tilt angle. (B) Mirrors in the ON position
will direct incident light perpendicular to the face of the DMD while mirrors
in the OFF state will direct light off axis. (C) Diffraction patterns produced
by coherent light illuminating the DMD.
Isolating light from an single order at a specific wavelength requires adjusting
the incident angle until the intensity envelope is aligned with the desired order.
This will result in the outbound light no longer being normal to the face of
the DMD, which can complicate downstream alignment. Alternatively, the
diffracted light can be collimated and focused onto to the desired projection
location using a pair of lenses. This effectively images the face of the DMD to
the sample plane using the same alignment procedure as incoherent light.
Alignment of the DMD was performed using a second camera (acA1300-
60gmNIR, 1280 x 1024 pixels, Basler AG) placed at the focus of the objective
lens to directly image the projected light. This was necessary because the
two dichroic beamsplitters prevent excitation light from reaching the primary
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Figure 2.7: Test patterns used to perform and verify alignment of the DMD-
projected light (Scale bars = 1 mm).
system camera. An internal checkerboard pattern on the DLP® LightCrafter™
and external binary masks were used to verify that the diffraction orders
were properly converging onto the sample plane (Figure 2.7). These images
also verified the 0.5x optical magnification applied to the projected patterns.
Because the DMD has a rectangular aspect ratio, the circular illuminating beam
slightly underfills the active area, resulting in some peripheral mirrors being
unusable for patterning. The Gaussian beam also produces a non-uniform
intensity profile, which would be problematic for intensity-based imaging
techniques but fortunately has minimal effect on lifetime measurements.
2.1.4 DMD Registration
In order to use the Speckle Software to define arbitrarily-shaped patterns,
the camera FOV must be registered with the projection area of the DMD.
An affine transform is used to translate, scale, shear, and rotate the mask
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from the camera coordinate system to the DMD coordinate system without
linear distortion. The matrix representation of the 2D affine transform using
homogeneous coordinates is defined as:x′y′
1
 =
a b cd e f
0 0 1
xy
1
 (2.1)
where (x, y) represent camera coordinates and (x′, y′) represent DMD coordi-
nates. The Speckle Software performs the registration by prompting the user
to identify the positions of three sequentially projected points in the camera
FOV and then inverting Equation 2.1 to solve for the six coefficients of the
transformation matrix. While the dichroic beamsplitters limit the amount of
excitation light that reaches the camera, the speckle contrast calculation is
sensitive to the intensity changes when the bandpass filter is removed. The
user can then define an ROI using the speckle contrast image for reference and
the affine transform will be applied to the mask as it is uploaded to the DMD
(Figure 2.8).
2.1.5 Laser Diode Stability
Laser diode stability is extremely important when performing LSCI
because the technique is sensitive to changes in coherence and lasing wave-
length. Regulated thermoelectric cooling (TEC) has been shown to significantly
improve the stability of laser diode operation and reduce noise during LSCI
measurements [96]. Identifying stable laser operating conditions requires ad-
justing the laser diode current and the TEC temperature setpoint. The 685
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Camera Mask DMD Mask Projected Mask
Figure 2.8: Example of the affine image transformation applied to the camera
coordinate space binary mask and the resulting DMD-projected pattern as
imaged using LSCI (Scale bar = 1 mm). Adapted from [91].
nm laser diode used for LSCI has a recommended operating current of 75
mA and exhibits temperature-dependent changes in slope efficiency and lasing
wavelength.
The diode was tested under different operating conditions by imaging a
static piece of paper and examining the stability of the intensity and speckle
contrast over time within the center quadrant of the camera FOV (Figure
2.9A). A total of nine conditions were tested with laser diode currents varied
between 65, 70, and 75 mA and TEC temperatures varied between 17, 18, and
19 ◦C. The system was allowed to stabilize for five minutes after changing a
parameter before acquiring LSCI data for ten minutes.
As expected, higher laser diode operating currents resulted in higher
intensity values. With the exception of the 75 mA current at 19 ◦C condi-
tion, minimal fluctuations in intensity were seen over time. However, the
speckle contrast measurements exhibited much greater variation within and
36
75
85
95
105
115
125
In
te
ns
ity
Laser Operation and LSCI Stability
0 100 200 300 400 500 600
Time (s)
0.12
0.16
0.20
0.24
Sp
ec
kle
 C
on
tra
st
65mA 70mA 75mA
Laser Diode Current
0
2
4
6
8
Co
ef
fic
ien
t o
f V
ar
iat
ion
 (%
)
Speckle Contrast Relative Variance
65mA @ 17°C
65mA @ 18°C
65mA @ 19°C
70mA @ 17°C
70mA @ 18°C
70mA @ 19°C
75mA @ 17°C
75mA @ 18°C
75mA @ 19°C
A
B
Figure 2.9: (A) Intensity and speckle contrast timecourses under different laser
diode operating conditions. (B) Measurement of relative variance between the
different speckle contrast data to identify the optimal laser diode operating
conditions.
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between acquisitions. Significant mode hopping, where the laser suddenly
switches to a different resonator mode resulting in a discrete jump in the
center wavelength, can be seen in both the 65 mA current at 18 ◦C and 75 mA
current at 19 ◦C conditions. Mode hopping manifests in diode lasers because
of temperature transients and non-ideal TEC operating temperatures. These
fluctuations severely impact LSCI measurements and operating conditions must
be optimized to mitigate them.
In order to identify the best operating parameters, the coefficient of
variation (CV = σ / µ) for each speckle contrast timecourse was computed
(Figure 2.9B). This statistic allows for the comparison of variation between
data series with different means, with smaller values indicating less variance.
Based on this metric, the 75 mA laser diode current at the 17 ◦C TEC setpoint
offered the best stability (CV = 0.05%) for LSCI measurements. The stability
of these settings were verified across two additional days of tests and were used
exclusively throughout the remainder of this dissertation.
2.2 Oxygen Tension Measurements in Cuvettes
Phosphorescence lifetime measurements were first tested in normoxic
and anoxic cuvettes of 10 µM Oxyphor PtG4. The normoxic cuvette was
prepared under ambient conditions and therefore has pO2 equivalent to that
of air (∼150 mmHg). The anoxic (0 mmHg) cuvette was created using the
enzymatic reaction between glucose and glucose oxidase to scavenge oxygen
from the sealed environment [97]. Phosphorescent decays (n = 200) were
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Figure 2.10: (A) Averaged phosphorescent decay curves (n = 200) in anoxic
and normoxic cuvette environments with fitted lifetimes and their corresponding
pO2 values. (B) Excitation wavelength does not affect measured pO2 (mean
± s.d.). Adapted from [91].
acquired using both 445 and 637 nm excitation with all DMD pixels in the ON
position. The resulting decay curves were averaged and fitted for τ and the
calibration curve used to lookup the corresponding pO2 value (Figure 2.10A).
For both excitation wavelengths, the normoxic cuvette pO2 was 152 mmHg
while the anoxic cuvette pO2 was 0 mmHg (Figure 2.10B).
2.2.1 Fitted Lifetime Discrepancy
The lifetimes of fluorescent and phosphorescent decays are independent
of excitation wavelength. Targeting the Soret or Q band absorption maxima
of a porphyrin should result in identical measurements of τ since internal
conversion and vibrational relaxation occur on picosecond timescales. However,
discrepancies in the phosphorescent decays were identified between 445 and 637
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nm excitation (Figure 2.11A). Fitting the exponential decays produced different
values of τ from the same cuvette depending on the excitation wavelength.
Since τ cannot vary with wavelength, this discrepancy likely arises because
the two lasers are modulated using different mechanisms. The 445 nm laser
is optically modulated using an AOM while the 637 nm laser is electronically
modulated using its driver. Ideally both light sources should be modulated
using the same technique to eliminate differences in bandwidth and modulation
depth that can manifest in the optical signal.
In order to correct for this error, the exponential decay fitting process
was modified with a temporal offset to ensure that both wavelengths would
produce the same lifetime values. Figure 2.11B depicts the relationship between
the offset and the resulting fits for τ in the normoxic cuvette. As the offset is
increased, the fitting is biased towards longer lifetimes. The optimal offsets
were identified at t = 21.50 µs for 445 nm excitation and t = 26.54 µs for
637 nm excitation. These offsets result in a fitted τ = 16.993 µs (pO2 = 152
mmHg) and are used throughout this dissertation. A major disadvantage of
this strategy is the waste of phosphorescent signal. In the normoxic cuvette,
these offsets correspond to 96% and 60% of the peak phosphorescence intensity
for 445 and 637 nm excitation, respectively. While the exact percentage scales
with τ , this can have detrimental effects on fitting performance for weak signals.
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Figure 2.11: (A) 445 and 637 nm excitation produce different phosphorescent
decay curves in identical samples. (B) Introducing an offset into the exponential
decay fitting process corrects the wavelength-dependent lifetime discrepancy.
2.2.2 Limitations of the Calibration Curve
Performing measurements on the normoxic cuvette revealed a limitation
of the Oxyphor PtG4 calibration curve (Figure 2.1B), which has a maximum
pO2 of 160 mmHg. While this is well beyond normal physiological values,
any measurements conducted in animal subjects receiving supplemental oxy-
gen would require using the Stern-Volmer relationship to convert τ into pO2.
However, the calibration curve does not fit the Stern-Volmer relationship par-
ticularly well (R2 = 0.9729) and results in a discontinuous transition between
the two methods (Figure 2.12). Lifetime measurements shorter than 16.6 µs
will abruptly drop from 160 to 134 mmHg. Because of this deviation from the
expected kinetics, there is significant uncertainty in the true pO2 values beyond
the range of the empirical data. Despite this limitation, the combination of the
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Figure 2.12: Least-squares fitting of the Stern-Volmer relationship to the
Oxyphor PtG4 calibration data and the resulting prediction for lifetimes down
to 10 µs. For τ ≥ τ0, pO2 is set to 0 mmHg.
calibration curve and the fitted Stern-Volmer parameters are used throughout
this dissertation. The calibration curve is used when 16.6 µs ≤ τ < 47 µs and
the Stern-Volmer relationship is used when τ < 16.6 µs. When τ ≥ 47 µs (τ0),
pO2 is set to 0 mmHg.
2.3 Demonstration of Acute In Vivo Imaging
The system was tested in vivo using mice (CD-1, male, 25-30 g, Charles
River) with permanent cranial window implants (see Appendix C) that afford
optical access to the surface of the brain. The window was positioned over
the frontoparietal cortex approximately 2 mm rostral from bregma and 0.5
mm lateral from the sagittal suture. Animals with clear and healthy cranial
windows were selected for use after at least two weeks of recovery post-surgery.
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The subject was anesthetized with medical air vaporized isoflurane (1.5%)
via nose-cone inhalation and placed supine in a head-fixed stereotaxic frame
(Narishige Scientific Instrument Lab). Oxygen gas was intentionally avoided
to prevent hyperoxia from interfering with the pO2 measurements. Vitals
including oxygen saturation, heart rate, and breath rate were monitored via
pulse oximetry (MouseOx, Starr Life Sciences) and temperature was regulated
with a feedback heating pad (DC Temperature Controller, FHC). Oxyphor
PtG4 was administered via retro-orbital injection into the venous sinus for a
target blood plasma concentration of 5 µM. The subject was then placed under
the dual-modality system for imaging.
Figure 2.13 depicts an averaged (n = 45) speckle contrast image and its
corresponding ICT image highlighting the vasculature of the cortex. Speckle
contrast images in this document are displayed using a grayscale colormap
spanning the full range of the speckle contrast histogram. ICT images are
displayed on a logarithmic scale using a perceptually-balanced colormap [98]
spanning the full range of the ICT histogram. Compared to the speckle contrast
image, the ICT image more clearly depicts the flow profiles within the larger
vessels.
Static oxygen tension measurements were acquired from two arterioles,
two veins, and one parenchyma region using both the 445 and 637 nm excitation
lasers (Figure 2.14A). Patterns were displayed at 1 Hz for a total of 5 seconds
with 2500 phosphorescent decays averaged per ROI. The measured pO2 within
each region aligns well with physiological expectations with both arterioles
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Figure 2.13: (A) Speckle contrast and (B) ICT images of the mouse cortex
(Scale bars = 1 mm).
exhibiting higher pO2 than the venous or parenchyma areas (Figure 2.14B). The
effects of wavelength can be seen as 445 nm excitation resulted in a broader
range of pO2 values (48-83 mmHg) compared to 637 nm excitation (75-82
mmHg). Despite differences in absolute value, the trend of arterioles having
greater pO2 than parenchyma, which in turn has greater pO2 than veins, exists
for both excitation wavelengths. Since lifetime does not depend upon excitation
wavelength (Figure 2.10B), these differences likely arise because of increased
penetration depth at the longer wavelength.
In order to obtain a more comprehensive look at vascular oxygenation
within the camera FOV, an array of 12 x 8 rectangular tiles was sequentially
projected using the DMD. The tiles were displayed at 10 Hz with 250 decays
averaged per pattern for a total acquisition time of 9.6 seconds. The resulting
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Figure 2.14: (A) Speckle contrast image of cortical flow overlaid with regions
targeted for pO2 measurements. Two descending arterioles (A1, A2), two veins
(V1, V2), and one parenchyma region (P1) were examined. The projected
patterns ranged between 0.014-0.046 mm2 in area. (B) pO2 measurements
within the targeted regions conducted using both 445 and 637 nm excitation
of Oxyphor PtG4 (mean ± s.d.). (C) 445 nm and (D) 637 nm pO2 maps
produced using tiled excitation patterns covering a 1.2 x 1.0 mm area. Each
individual tile has a projected area of 0.012 mm2 (Scale bars = 1 mm). Adapted
from [91].
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pO2 maps (Figure 2.14C-D) coarsely follow the visible surface vasculature.
As expected, the large branching vein has lower pO2 values compared to
the arteriole approaching from the bottom of the FOV or the surrounding
parenchyma. 445 nm excitation again resulted in a wider range of pO2 values
(45-85 mmHg) compared to 637 nm excitation (81-85 mmHg).
2.3.1 Hyperoxic Challenge
The ability to detect changes in cortical oxygen tension was tested using
an hyperoxic challenge. The oxygen fraction of inspired air under anesthesia was
increased from 21% (normoxia) to 100% and then decreased back to normoxia
for recovery. Hyperoxia was maintained for five minutes and pO2 measurements
using 445 nm excitation were acquired at the end of each stage from three
regions covering an arteriole, venule, and parenchyma (Figure 2.15A). The
patterns were displayed at 1 Hz with 2500 phosphorescent decays averaged per
ROI. A large increase in pO2 was detected during the hyperoxic state across
all three regions (Figure 2.15B) with the arteriole experiencing the largest net
increase (+120 mmHg). The pO2 remained slightly elevated above baseline
values several minutes later during the post-hyperoxia recovery stage.
The measured lifetime in the arteriole during hyperoxia was only 13.1
µs and therefore exceeded the limits of the Oxyphor PtG4 calibration curve
(Section 2.2.2). The Stern-Volmer relationship was used to calculate the pO2
and likely underestimates the actual value. While it is counterintuitive for
the arteriole to experience the largest increase in pO2, similar results were
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Figure 2.15: (A) Speckle contrast image depicting three regions (arteriole,
venule, and parenchyma) targeted for 445 nm pO2 measurements during an
hyperoxic challenge (Scale bar = 1 mm). (B) Static pO2 during baseline,
hyperoxic, and recovery stages for each of the targeted vessels (mean ± s.d.).
Adapted from [91].
seen during hyperoxic retinal imaging in both mice and rats [83]. A potential
explanation for this outcome is that hemoglobin in arterioles are already near
complete oxygen saturation and therefore hyperoxia causes a minimal increase
in SO2. However, veins and capillaries will experience a larger change in SO2
and therefore the apparent increase in pO2 will be smaller than that of an
arteriole because more of the oxygen is binding to hemoglobin.
2.3.2 Effects of Excitation Wavelength on Measured pO2
The results in Figure 2.14 revealed major differences in measured pO2
depending on excitation wavelength. The static pO2 measurements under
445 nm illumination spanned a range five times larger than that of 637 nm
illumination. This discrepancy was most noticeable in venous regions, with
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the shorter excitation wavelength resulting in pO2 values around 50 mmHg
whereas the longer wavelength resulted in values around 75 mmHg. Since depth
penetration is heavily dependent upon wavelength [99], the difference is likely
the result of photons sampling a much larger volume of tissue during 637 nm
illumination.
An estimate of transmission through a surface vessel at both wavelengths
can be obtained using the Beer-Lambert Law. Because scattering increases the
distance traveled by photons in tissue, this represents the most conservative
estimate of the effect of wavelength on transmission. Assuming hemoglobin is
the primary absorber in blood plasma with a concentration of 2.3 mM [100] and
95% SaO2, the transmittance at 445 nm and 637 nm through a 100 µm arteriole
is 0.9% and 96.5%, respectively. As excitation wavelength approaches the tissue
optical window, the transmission of incident light significantly increases. The
445 nm light is almost entirely confined within a vessel of that caliber and
does not extensively sample deeper microvasculature. Because the 637 nm light
penetrates further into the brain, the measured pO2 is skewed away from the
vascular value and is more representative of a bulk volumetric average. This is
consistent with prior Monte Carlo modeling that found fluorescence primarily
originates from within large surface vasculature at shorter wavelengths [101].
As excitation wavelength increases, a larger fraction of the detected fluorescence
originates from beyond the vessel.
These results indicate that excitation wavelength must be considered
when performing single-photon fluorescent or phosphorescent measurements
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using dyes with multiple excitation maxima. Longer wavelengths would not be
ideal for studying surface vasculature because of the increased penetration depth
but would be better suited for examining parenchyma regions or bulk areas.
Conversely, the limited penetration depth of shorter excitation wavelengths,
especially in vasculature, make them ideal for restricting measurements to only
surface tissue.
2.4 Discussion
The dual-modality imaging system combining LSCI and oxygen-dependent
quenching of phosphorescence is a purely optical, non-contact platform for
measuring relative blood flow and pO2. The system builds upon prior work
by Ponticorvo and Dunn [88] by using structured illumination to overcome
the traditional limitations of lifetime imaging. Spatially patterning excitation
light with a DMD allows for the use of a point detector, which offers both high
sensitivity and speed for the collection of the relatively weak phosphorescent
signal. Ultimately, the spatial and temporal resolutions of the phosphorescent
measurements are limited by noise. Regions as small as 0.01 mm2 could reliably
be excited at a pattern repetition rate of 10 Hz with 250 phosphorescent decay
curves accumulated per ROI. Because intensity of the excitation light scales
proportionally with the number of DMD pixels in the ON state, larger patterns
could allow for even faster pattern rates at the expense of averaging and spatial
resolution (e.g. 100 Hz with 25 decays averaged per ROI). However, a 10 Hz
pattern rate is more than sufficient for visualizing dynamic physiological events
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in the brain.
The transition to Oxyphor PtG4 eliminated many of the practical
concerns of older oxygen-sensitive phosphorescent probes and allowed for more
robust lifetime estimates [80]. The in vivo demonstrations of DMD-patterned
pO2 measurements aligned well with physiological expectations and could be
used to distinguish arterioles and venules based only on absolute pO2 values.
Excitation wavelength was shown to be an important consideration depending
on the imaging target with the shorter wavelength better suited for imaging
surface vasculature and the longer wavelength offering broader measurements
of bulk pO2. While the longer wavelength sampled a volume much closer to
that of the LSCI measurements, the larger range of pO2 values generated by
the shorter excitation wavelength were more useful.
50
Chapter 3
Spatially-Targeted Photothrombotic Stroke
Animal models of ischemic stroke are extensively used to study the
mechanisms of neuronal death and recovery and to perform preliminary testing
on neuroprotective interventions. While there are numerous techniques for
inducing focal ischemia, the majority rely upon occlusion of the middle cerebral
artery (MCA) and its branches. The MCA is the largest cerebral artery in the
brain and the most common vessel involved with human ischemic events [102].
The models that can most reliably reproduce the lesions and pathophysiology
of human stroke (e.g. ischemic core and penumbra) offer the best experimental
platforms for preclinical research.
Intraluminal MCA occlusion (MCAo) is the most widely used technique
and is performed by introducing a monofilament suture into the internal
carotid artery to block blood flow to the MCA [103]. This model is capable of
inducing both permanent and transient focal ischemia similar to that of human
stroke and does not require craniotomy. The procedure results in large-scale
infarct volumes (21-45% of ipsilateral hemisphere) that most closely resemble
malignant infarction in humans [104]. However, the majority of human strokes
are much smaller in size (4.5-14%) [104, 105], making traditional MCAo a
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poor model for studying recovery at a similar scale. Distal MCAo produces
smaller infarcts limited to the cerebral hemisphere but requires performing
a craniotomy to physically access the target vessel [106]. Embolic MCAo
relies upon the introduction of microspheres or the induction of thrombotic
clots to occlude downstream vasculature. Particle size dictates the extent and
localization of the infarction, which are more variable than traditional or distal
MCAo [104]. Vasoconstrictors such as Endothelin-1 (ET-1) can be injected
intracerebrally in the proximity of the MCA to induce transient ischemia with
a dose-dependent recovery of blood flow [102]. Surgical electrocauterization
or direct clipping of the MCA can also be performed to induce permanent or
reversible ischemia but require craniotomy.
The photothrombosis model uses intravascular photooxidation to gener-
ate well-defined cortical lesions [107]. Photosensitive dyes such as rose bengal
are injected intravenously and irradiated with light to produce singlet oxygen,
which causes localized endothelial damage initiating platelet aggregation and
thrombus formation [108]. Rose bengal has been extensively utilized as a
photothrombotic agent [109, 110] and has well-characterized pharmacokinetics
with fast clearance from the body [111]. A significant advantage of the pho-
tothrombotic model is the ability to stereotactically control the position and
size of the infarct to target specific functional regions. However, the technique
results in rapid vasogenic edema, which is thought to restrict the development
of the ischemic penumbra and local reperfusion [104].
The DMD in the imaging system offers a new method for targeting
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photothrombosis that allows for increased control over the stroke induction
process compared to conventional techniques that only illuminate a single focal
volume. Entire vessels, arbitrarily-shaped regions, or even multiple locations
can be simultaneously occluded by using the DMD to pattern the irradiating
light. By specifically targeting vessels, collateral photooxidative damage to the
surrounding tissue can be minimized. This chapter details modifications made
to the imaging system to perform DMD-targeted photothrombosis and an in
vivo demonstration of the technique in mice. The targeted photothrombosis
technique was described in a methods paper published in Neurophotonics [91].
3.1 Instrumentation Modifications
The system was modified (Figure 3.1) to perform photothrombotic
stroke with the addition of a 532 nm laser (200 mW, AixiZ LLC). The packaged
diode laser has a 2 mm collimated output that operates at a fixed current
with convection cooling. A neutral density filter (OD 1.0, NE10A-A, Thorlabs,
Inc.) was used to attenuate the laser intensity by an order of magnitude
down to 20 mW. A longpass dichroic beamsplitter (490 nm cutoff, DMLP490,
Thorlabs, Inc.) was used to coalign the 532 nm laser with the other two lasers
for coupling into the fiber optic patch cord. The green light can then be
patterned by the DMD for targeted photothrombosis. pO2 measurements can
be acquired simultaneously during photothrombosis induction because of the
system’s spectral separation, but are limited to only the stroke target region.
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Figure 3.1: The optical system was modified with the addition of a 532 nm laser
coupled into the fiber optic patch cord for DMD-targeted photothrombosis.
3.2 Targeted Photothrombosis Induction
Targeted photothrombosis was demonstrated in vivo using anesthetized
(1.5% isoflurane in medical air) mice with permanent cranial window implants.
Rose bengal was administered intravenously via retro-orbital injection (50 µL,
15 mg/mL) and the subject was immediately exposed to DMD-patterned green
light for 5-10 minutes. Descending arterioles were the primary targets because
they serve as bottlenecks in the cortical oxygen supply [112]. Target vessels were
identified based on vascular orientation and a posteriori knowledge. Because
Oxyphor PtG4 has minimal absorbance of green light, pO2 measurements can
be simultaneously acquired while performing photothrombosis. However, the
measurements were limited to only the region being targeted for occlusion.
LSCI was used to monitor clot formation within the targeted area and to control
the progression of the occlusion. The open source image registration software
elastix [113] was used during post-processing to correct the speckle contrast
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images for any motion relative to the beginning of the acquisition. This would
infrequently occur if the animal was not properly secured in the stereotaxic
frame. The automatic intensity-based transform allowing for rotation and
translation was applied to each speckle contrast frame. The computed speckle
contrast inverse correlation times (ICT = 1/τc) were then baselined against
pre-stroke values to provide an estimate of the relative change in blood flow
(rICT = τc,initial/τc).
Figure 3.2 depicts the targeted photothrombotic occlusion of a descend-
ing arteriole that is likely a distal branch of the MCA. The red overlay in Figure
3.2A highlights the 0.09 mm2 region irradiated with spatially-patterned green
light for 420 seconds. pO2 measurements were continuously acquired from the
same region at 1 Hz with 2500 decays averaged per record. The series of speckle
contrast images depict the progression of the photothrombotic occlusion as the
targeted vessel rapidly underwent stenosis and flow was significantly reduced.
After only two minutes of exposure, the targeted vessel was indistinguishable
from the surrounding parenchyma.
Figure 3.2B depicts the five regions (two arterioles, one vein, two
parenchyma) targeted for dynamic relative blood flow and pO2 measurements.
The first arteriole region (A1) is the same vessel targeted for photothrombotic
occlusion. The resulting timecourses of relative blood flow and pO2 within
each region can be seen in Figure 3.2C. By t = 120 seconds, flow within the
targeted arteriole had decreased to <50% of baseline and pO2 had dropped
from 80 mmHg to only 20 mmHg. Over the following several minutes, flow
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Figure 3.2: (A) Speckle contrast images depicting the occlusion of a descending
arteriole using DMD-targeted photothrombosis. The red overlay indicates the
0.09 mm2 region simultaneously illuminated for occlusion and pO2 measure-
ments. (B) Two arterioles (A1, A2), one vein (V1), and two parenchyma
regions (P1, P2) were targeted for pO2 measurements after stroke induction.
(C) Relative blood flow and pO2 within the targeted regions during and after
photothrombosis. The green-shaded section indicates irradiation of the tar-
geted arteriole. The arrow indicates the propagation of an ischemia-induced
depolarization event (Scale bars = 1 mm). Adapted from [91].
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Figure 3.3: Relative flow during an ischemia-induced depolarization event that
results in the expansion of the flow deficit. The depolarization has minimal
effect upon the large draining vein. (Scale bar = 1 mm).
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also decreased in the nearby parenchyma and venous regions (P1 and V1) and
increased slightly in the distal second arteriole region (A2). The propagation of
an ischemia-induced depolarization event [53, 114] can be seen beginning at t =
300 seconds, with sharp reductions in both relative blood flow and pO2. As the
depolarization subsided, flow within the targeted arteriole further decreased
to <35% of baseline flow while the pO2 returned to pre-depolarization levels
around 20 mmHg. Flow in all other regions remained depressed immediately
following the depolarization. Figure 3.3 overlays relative ICT on speckle con-
trast imagery to depict the spatial extent of the depolarization and the resulting
increase in deficit area. This global reduction in flow following a spreading
depolarization is consistent with previous studies using other stroke models
[53, 115].
Photothrombosis irradiation was stopped at t = 420 seconds and pO2
measurements from all five ROIs were initiated. Patterns were displayed at
2 Hz with 1250 decays averaged per record. Flow and pO2 decreased over
the remaining 20 minutes of the imaging session across all regions except for
A1. At t = 860 seconds, the targeted vessel partially reperfused, causing an
abrupt increase in both relative blood flow (+6 percentage points) and pO2
(+15 mmHg). By the end of the imaging session, flow had increased within A1
to 55% of baseline and pO2 to 42 mmHg, likely indicating further reperfusion
of the vessel.
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3.3 Chronic Post-Stroke Hemodynamics
The chronic progression of the ischemic lesion was monitored for eight
days following photothrombosis. The subject was anesthetized (1.5% isoflurane
in medical air) and positioned on the stereotaxic frame such that the speckle
contrast imagery was aligned with previous acquisitions. Imaging sessions were
kept as short as possible (<30 minutes) to avoid over-exposure to isoflurane.
The perfusion of the occluded arteriole and broader effects on cortical flow were
tracked using LSCI as shown in Figure 3.4A. Tiled pO2 maps acquired using
both 445 and 637 nm excitation (Figure 3.4B-C) reveal the spatial extent of
the oxygen deficit. The broad value range of the colormap masks the smaller
pO2 differences between arterioles and venules. A large gradient can be seen
between the occluded vessel and surrounding tissue on Days +1 and +2 despite
partial reperfusion of the targeted vessel. This gradient resembles the ischemic
penumbra that the photothrombotic technique rarely produces [104]. By Day
+5, the targeted arteriole had fully reperfused and the hypoxic region recovered
to near baseline.
The same five regions (two arterioles, one vein, and two parenchyma)
used during the acute photothrombosis measurements were also targeted for
chronic relative blood flow and pO2 measurements (Figure 3.4D-F). The relative
blood flow was calculated using the spatial average of the pre-stroke (Day -0)
ICT measurements as the baseline. The first post-stroke measurements (Day
+0) were taken immediately after the induction of photothrombosis and revealed
global deficits in both blood flow and pO2. This systemic change is likely the
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Figure 3.4: Progression of the ischemic lesion over eight days as imaged with (A)
LSCI, (B) 445 nm tiled pO2, and (C) 637 nm tiled pO2 measurements. Day
-0 measurements were taken immediately prior to photothrombosis induction
and Day +0 measurements were taken immediately after. (D) Two arterioles
(A1, A2), one vein (V1), and two parenchyma regions (P1, P2) were targeted
for chronic (E) relative blood flow and (F) 445 nm pO2 measurements (mean
± s.d.). The relative blood flow was baselined against Day -0 measurements.
(Scale bars = 1 mm). Adapted from [91].
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result of the spreading depolarization, which have previously been shown to
cause global reductions in CBF using other stroke models [53, 115]. The blood
flow and pO2 within the ROIs mirror the recovery seen in the spatially-resolved
results with the vessel fully reperfusing by Day +5.
The speed of this recovery is faster than previous traditional pho-
tothrombotic inductions performed by the lab, which took 3-4 weeks to return
to baseline flow levels [116]. This discrepancy can be explained by the smaller
area targeted for photothrombosis (0.09 mm2 vs. 0.28 mm2) and the lower
irradiance (<15 mW/mm2 vs. 72 mW/mm2) within the area of illumination,
which resulted in a less severe ischemic lesion. Confinement of the excitation
light to only within the targeted arteriole minimized collateral damage to the
surrounding vasculature and parenchyma and allowed the infarct to manifest
downstream of the occlusion. The lack of reperfusion is also a common critique
of the traditional photothrombotic model of stroke [104].
3.3.1 Persistence of Oxyphor PtG4 In Vivo
Oxyphor PtG4 is a large molecule with a molecular weight around 35
kDa. The majority of its size arises from the PEGylated hydrophobic dendrimer
surrounding the PtTBP core used to increase biocompatibility and lifetime
stability. Pilot experiments with Oxyphor PdG4, an analog with a palladium
core, found that it was retained in the bloodstream for hours and readily
accumulated within tumors via the enhanced permeability and retention effect
[80]. This allowed animals to be imaged up to a day after being injected with
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10 µM Oxyphor PdG4.
Oxyphor PtG4 persists in the bloodstream significantly longer than
previously reported in literature. Strong phosphorescent decay curves have be
obtained up to two weeks after an initial injection of the dye with a target
blood plasma concentration of 5 µM. The mouse utilized for the targeted
photothrombosis and eight days of chronic hemodynamic imaging described
above was only administered a single dose of Oxyphor PtG4 on the first day
of imaging. While this allows for efficient usage of a limited supply of dye, it
remains unclear how and where the probe persists in the bloodstream for such
an extended period of time. Phosphorescent intensity does decrease day-to-day,
which means that the probe does not remain indefinitely. However, if the
protective dendrimer structure is being degraded, then the reliability of the
lifetime measurements is a major concern. Unfortunately, it would be difficult
to validate the correct pO2 using a different technique in vivo or to replicate
the appropriate testing conditions in vitro. In order to mitigate the impact
of these uncertainties, supplemental injections of Oxyphor PtG4 for a blood
plasma concentration of 5 µM were administered weekly in subjects being used
for chronic imaging.
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3.4 Functional Effects of Targeted Photothrombosis
A comprehensive comparison between traditional and artery-targeted
photothrombosis using the DMD was performed by Taylor A. Clark1. This
section presents results on the functional impairments caused by targeted
photothrombosis in the motor cortex. A total of 23 young-adult (4-6 months)
C57/Bl6/YFP-H mice were used to examine the impact on skilled forelimb
function, with subjects undergoing targeted photothrombosis (n = 13) or
sham procedures (n = 10). Mice with cranial windows were anesthetized with
O2-vaporized isoflurane (4% induction, 1.5-2% maintenance) via nose-cone in-
halation and placed in a head-fixed stereotaxic frame. Vitals including oxygen
saturation, heart rate, and breath rate were monitored via pulse oximetry and
temperature was regulated with a feedback heating pad. Rose bengal was ad-
ministered via retro-orbital injection (50 µL, 15 mg/mL) and photothrombosis
was initiated after a 30 second delay. Sham subjects received injections of
sterile saline. DMD-targeted photothrombosis was performed by irradiating
pial arteries supplying the forelimb region of the motor cortex as defined from
intracortical mappings [117] for 5 minutes. In order to account for variations
in the size and caliber of the vessels, a range of 1-3 branches were illuminated
with an average total targeted area of 0.15 ± 0.021 mm2. The primary vessels
1The results of this section are adapted from a manuscript currently under review as
‘T. Clark, C. Sullender, S. Kazmi, B. Speetles, M. Williamson, D. Palmberg, A. Dunn,
and T. Jones. Artery targeted photothrombosis enlarges the vascular penumbra, instigates
peri-infarct neovascularization and models upper extremity impairments.’ C.S. developed the
instrumentation and performed the targeted photothrombosis inductions. T.C. performed
the experiments, analyzed the results, and wrote the manuscript.
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targeted in all subjects were distal branches of the MCA. Photothrombosis
progression was monitored in real-time using LSCI.
3.4.1 Single Seed Retrieval Task
The resulting impact on forelimb function was quantified by testing
performance during a skilled reaching task. The task was a variation of the
single seed retrieval task [118] where mice are trained to reach for and obtain
a millet seed placed on a platform outside of transparent training chamber. A
pair of 4 mm wide vertical openings on the left and right sides of the chamber
permitted the mice to reach through with only the corresponding paw (Figure
3.5A). The external platform contained three wells at varying distances from
each opening for the placement of seeds (Figure 3.5B). Two of the wells were
centered on the opening and positioned at distances 3 mm (Position 1) and
7 mm (Position 2) away from the chamber. The third well (Position 3) was
placed 2 mm lateral of the distal edge of the opening and 5 mm away from the
chamber.
The preferred limb for reaching was determined during shaping by
allowing the mice to reach for millet seeds with either limb when seeds were
placed immediately outside both openings. The preferred-for-reaching limb was
defined as the first one used to make five consecutive reach attempts (Figure
3.5C). For the remaining 2-3 days of the shaping phase, mice were encouraged
to reach for a single seed placed in Position 1 with their preferred-for-reaching
limb. The shaping phase concluded once mice were able to successfully retrieve
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Figure 3.5: (A) The transparent training chamber and pair of 4 mm vertical
openings used for performing the reaching task. Adapted from [118]. (B) The
three positions used for seed placement outside of each opening. (C) A mouse
reaching for a seed. (D) Training and measurement timeline for the behavioral
experiments.
the seed 10 times (Figure 3.5D). The mice then underwent 10 consecutive days
of training sessions, each comprised of 30 trials. Seeds were placed in one of
the three positions per trial, with each position recurring ten times per training
session in a randomized order. Mice were permitted four reaching attempts
per trial with a successful reaching attempt defined as grasping the seed and
bringing it inside the chamber to its mouth. Unsuccessful reaching attempts
included missing, displacing, or dropping the seed prior to eating.
The mean asymptotic performance (average of the last two training
days) prior to photothrombosis inductions for each of the three positions were
0.44 ± 0.02 (Position 1), 0.3 ± 0.02 (Position 2), and 0.2 ± 0.01 (Position 3).
Because performance on Position 3 was much lower compared to the other two
positions, it was excluded from analysis. Results were reported as the percent
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of successful reaches per reaching attempt for Positions 1 and 2. Performance
was tested on Days 3, 5, 10, and 20 following photothrombosis induction or
sham procedure. The SPSS Statistics (IBM Corp.) software package was used
to examine reaching performance between the stroke and sham groups over
time using two-way repeated measures ANOVA.
3.4.2 Tissue Processing and Analysis of Lesion Volume
Animals were euthanized 30 days after photothrombosis with sodium
pentobarbital and transcardially perfused with 0.1 M phosphate buffered saline
and 4% paraformaldehyde. The brains were extracted and stored in 4%
paraformaldehyde for no more than 48 hours before using a vibrating blade
microtome (VT1000S, Leica Biosystems) to slice 40 µm coronal sections spaced
240 µm apart between approximately 1.34 mm anterior to 0.58 mm posterior to
bregma. The sections were Nissl stained in order to identify viable cortical tissue
and imaged with 17x magnification. The cortical volume was estimated with
Cavalieri’s Principle [119] using Neurolucida (MBF Bioscience) by computing
the product of the summed section areas and the distance between sections.
Lesion volume was then calculated as the difference between cortical volumes
of the contralateral and ipsilateral hemispheres [117].
3.4.3 Results
Artery-targeted photothrombosis in the motor cortex significantly im-
paired performance on the skilled reaching task compared to the sham control
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Figure 3.6: (A) Baseline and post-stroke reaching performance measured by
the ratio of successfully retrieved seeds per reaching attempt (mean ± s.e.).
Artery-targeted photothrombosis impaired performance on post-stroke Days 3,
5, and 10 compared to the sham procedure (** p < 0.001, * p < 0.02). (B)
Averaged lesion reconstructions overlaid on coronal templates. The numbers
indicate the anterior-to-posterior coordinates relative to bregma. (C) Volume
difference between the contralateral and ipsilateral hemispheres as an estimate
of infarct size (mean ± s.e.).
on Days 3, 5, and 10 (Figure 3.6A). Two-way repeated measures ANOVA of
reaching performance over time revealed a significant effect in the stroke vs.
sham grouping (F[1,23] = 145.50, p < 0.0001) but no significant interaction in
grouping over time (F[3,69] = 2.77, p = 0.06). By Day 20, performance on the
reaching test in the stroke group was similar to that of the sham group. This
transience is likely a byproduct of the relatively small infarcts (Figure 3.6B-C).
Nevertheless, these results suggest that artery-targeted photothrombosis is
suitable for creating reproducible focal lesions in the motor cortex that can be
used to model upper extremity impairments.
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3.5 Discussion
The addition of a green laser to the DMD illumination pathway facilitates
the induction of arbitrarily-shaped photothrombotic lesions. The system allows
for greater control over the spatial characteristics of the induced stroke (e.g.
size and location) and permits targeting multiple vessels simultaneously. The
creation of an extended occlusion within a single arteriole using targeted
photothrombosis was demonstrated for the first time. This is a significant
change from existing photothrombotic techniques that generally rely upon
broad illumination to occlude a large volume of vasculature [107, 116] or highly-
focused light to occlude a single microvessel [120]. The previous iteration of
this system could only induce occlusions within a large region relative to the
FOV and pO2 measurements could not be simultaneously acquired [88].
While tissue pO2 during ischemic depolarizations have been previously
examined [121], the results reported in Neurophotonics [91] represent the
first quantification of the acute vascular pO2 response to a depolarization
event and the first chronic hemodynamic tracking of an ischemic infarct. The
depolarization resulted in a global flow reduction across all regions, which is
consistent with previous reports using other stroke models [53, 115]. Within
the targeted arteriole, the blood flow reduction is of greater magnitude (-58%)
than the corresponding decrease in pO2 (-44%), which eventually recovers to
slightly above pre-depolarization levels. Unfortunately, it is difficult to predict
how the pO2 responded to the depolarization across the other regions, but it
likely mirrored the LSCI results. The chronic measurements revealed a rapid
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recovery over the course of five days with the spatial extent of the ischemic
lesion clearly visible on the first two days post-stroke. Functional tests revealed
that the artery-targeted photothrombotic model of ischemic stroke could be
used to produce detectable and reproducible impairments in upper extremity
motor skills. The deficits recovered over the course of several weeks despite the
relatively minor lesions.
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Chapter 4
Improving Cerebral Blood Flow
Measurements with Multi-Exposure Speckle
Imaging
While the conventional LSCI technique can provide reliable measure-
ments of relative flow, it is incapable of quantifying absolute baseline values.
This complicates the chronic study and inter-animal comparisons of blood
flow dynamics because variations in imaging conditions cannot be properly
accounted for by the underlying model. This has not prevented LSCI from
being used to study chronic changes in flow (see Section 3.3), but has limited the
observations to predominantly qualitative interpretations [51]. The technique
has also been shown to underestimate large changes in relative flow and fails
to produce reliable measurements in the presence of static scatterers [71].
Multi-exposure speckle imaging (MESI) is an extension to traditional
LSCI theory that accounts for static scattering and produces a more robust
estimate of τc using multiple camera exposure times [71]. These improvements
are achieved by accounting for the heterodyne mixing of dynamic and static
scattering contributions, the non-ergodicity of light, and exposure-independent
noise. The model described by Parthasarathy et al. [71] again relates the
measured K with τc:
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K(T, τc) =
(
βρ2 e
−2x−1+2x
2x2
+ 4βρ(1− ρ) e−x−1+x
x2
+ β(1− ρ)2 + νne + νnoise
)1/2
(4.1)
where x = T/τc, T is the camera exposure time, β is the same normalization
factor that accounts for speckle averaging effects, ρ is the fraction of light that
is dynamically scattered, νne is the constant variance due to nonergodic light,
and νnoise is the exposure-independent instrument noise. For simplicity, νne
and νnoise are typically merged into a single noise parameter (νnoise). Similar
to Equation 1.2, this expression assumes that detected photons only experience
single scattering interactions and that the underlying particle motion has
a Lorentzian velocity distribution. A scaling term representing the number
of average dynamic scattering events can be included with x to account for
multiple scattering interactions [38]. In the absence of static scatterers, ρ→ 1
and Equation 4.1 simplifies to Equation 1.2, excluding the noise terms. In the
presence of only static scatterers, then ρ → 0 and K reduces to a constant
β + νnoise and is independent of exposure time. This represents the upper
limit of the speckle variance (K2) curve and can be approximated with just β
because the noise will only constitute a small percentage of the total value.
A minimum of four speckle contrast images acquired at different exposure
times are necessary to fit Equation 4.1 for the four unknown variables (β, ρ,
τc, νnoise). In practice, 15 images spanning three decades of exposure times
(50 µs - 80 ms) are typically utilized to sample as much of the underlying
flow distribution as possible. The MESI model has improved the quantitative
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accuracy of flow measurements in controlled microfluidic environments [71, 38]
and closely approximates the results of direct autocorrelation measurements
[122]. The technique has enabled the chronic study of CBF across multiple
animals and improved the robustness of flow deficit measurements during stroke
[110, 123, 116]. This chapter details an upgrade to the imaging system to
perform MESI and further validation of its capabilities.
4.1 Instrumentation Modifications
The instrumentation necessary for performing MESI is similar to tradi-
tional LSCI but requires precise control over both the camera exposure time and
the laser intensity. Varying the exposure time alone would result in shot noise
overwhelming the speckle signal at longer exposure times because of differences
in intensity. However, by modulating the amplitude of the illuminating laser
light, the average intensity of the images, and therefore the shot noise, can be
held constant. Passive optical devices such as AOMs have historically been
used to avoid the bandwidth and dynamic range limitations of direct laser
diode modulation.
Figure 4.1 depicts the modifications made to the LSCI illumination
pathway in order to perform MESI with the system. The same 685 nm laser
diode (50 mW, HL6750MG, Thorlabs, Inc.) was collimated using an aspheric
lens (C240TME-B, Thorlabs, Inc.) and the beam diameter was reduced to
1 mm. The light was modulated using a 100 MHz AOM (3100-125 AOM +
1110AF-AIFO-1.0 RF Driver, Gooch & Housego) with the first order diffraction
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Figure 4.1: The optical system was modified to perform MESI with the addition
of an AOM to modulate the 685 nm laser used for LSCI.
isolated and relayed to obliquely illuminate the sample. The camera was
also upgraded (acA1920-155um, 1920 x 1200 pixels, Basler AG) because the
previous model did not support trigger-based control of exposure duration,
which is important for implementing MESI. The new camera also offered more
convenient USB 3.0 connectivity, higher maximum frame rate (164 fps), lower
dark noise, and increased dynamic range. While the pixel resolution was almost
doubled, only a subset of the overall sensor array was used (1200 x 1000 pixels),
resulting in a FOV of 3.6 x 3.0 mm.
4.1.1 Acquisition Control
The MESI acquisition process is controlled by a combination of the
Speckle Software and a standalone MATLAB (MathWorks, Inc.) script. The
Speckle Software was updated to allow the camera to perform “Trigger Width
Exposure Mode” acquisitions, where the duration of a hardware trigger signal
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directly controls the exposure time of each frame. The MATLAB script used
the ANSI C NI-DAQmx library (National Instruments Corp.) to operate a
multifunction I/O device (USB-6363, National Instruments Corp.) to produce
the camera exposure trigger signals and AOM modulation voltages (Figure
4.2). Both waveforms were generated at 1 MHz with identical pulse durations
but a slight temporal offset (+25 µs delay for the AOM signal) to guarantee
that the actual camera exposures and the laser pulses were synchronized in
time. This was validated using the “Exposure Active” output signal from the
camera and a photodiode (PDA36A, Thorlabs, Inc.) directly measuring the
modulated laser.
A complete MESI frame consists of 15 raw intensity images (8-bit)
each acquired with a different exposure time for an effective frame rate of 2.5
fps without any averaging. This is significantly slower than standard LSCI
and insufficient to properly sample faster hemodynamic processes. Because of
limitations with the Speckle Software, the speckle contrast images cannot be
computed for real-time visualization during an acquisition. This requires the
speckle contrast images to be generated during post-processing. A standard
MESI acquisition produces data at a rate of 178 MB/s.
4.1.2 Calibration Procedure
The AOM modulation voltages for each exposure are determined using
the calibration procedure outlined in Figure 4.3. This process ensures that
shot noise is held constant across all exposures by equalizing the total amount
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Figure 4.3: Overview of the MESI calibration process that attempts to equal-
ize the raw image intensities while minimizing saturated pixels across all N
exposures.
of light used to produce each image. Because the reflectivity of the imaging
surface varies by sample, the calibration must be performed prior to each MESI
experiment.
The initial guess for the modulation voltages is generated using a power
law function confined between 0-1 V. These voltages are used to acquire
a complete MESI frame containing 15 raw intensity images from different
exposures. The average intensity and total number of saturated pixels within a
user-defined region is then calculated for each image. If the overall coefficient of
variation and the number of saturated pixels are less than the defined thresholds,
then the intensities are equalized and the calibration is complete. However, if
the average intensity variation is too high or if there are too many saturated
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pixels, then each of the modulation voltages are adjusted accordingly using the
shortest exposure time as the target intensity. This process repeats recursively
until the stop conditions are achieved. A typical calibration will take between
30-50 iterations and complete within less than a minute.
Figure 4.4 contains an example of the final iteration of a MESI calibration
for an in vivo imaging experiment. The intensity-equalized raw images for
each of the 15 exposures can be seen in Figure 4.4A. The speckle pattern
becomes increasingly blurred, especially within vascular regions, as the camera
integration time increases. The average intensity from the center quadrant of
each exposure is shown in Figure 4.4B, with a final coefficient of variation <1%.
Figure 4.4C depicts the resulting calibrated AOM modulation voltages for use
with each exposure time during the actual imaging experiment. The voltages
span two orders of magnitude (0.3 V - 3 mV) and cover the entire modulation
range of the AOM.
4.2 Improving MESI Processing Speed
The generation of a single MESI ICT frame is a computationally-
intensive task that requires fitting Equation 4.1 at every single pixel of the
input speckle contrast images. This has prohibited any real-time visualization
using the technique and limited most studies to ROI analysis rather than
full-field imagery. The original processing script developed by Parthasarthy
[124] and improved upon by Kazmi [125] relied upon the nonlinear regression
functions of MATLAB’s Optimization Toolbox. The fit() function was used
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Figure 4.4: (A) Raw images of a cranial window from each of the 15 MESI
exposures acquired using calibrated modulation voltages to equalize intensity
(Scale bar = 1 mm). (B) Average intensity from the center quadrant of each
image (mean ± s.d.). (C) Calibrated MESI modulation voltages for each
exposure time.
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to solve for the four variables (β, ρ, τc, νnoise) using the Trust-Region-Reflective
least squares algorithm [126]. This method was the only built-in algorithm that
offered bound constraints on the individual components, which were necessary
because all four variables are limited to values between (0, 1]. Because the
analytical Jacobian for the MESI Equation (Equation 4.1) was not explicitly
defined, the solver automatically approximated it using finite differences at
the expense of additional computation. While this processing script produced
reliable results, it was extremely slow and took hours to compute a single MESI
ICT image, making it impractical to generate more than a few frames.
In order to increase the processing speed, alternatives to the native MAT-
LAB optimization functions were examined. The Levenberg-Marquardt nonlin-
ear least squares algorithm has a popular ANSI C implementation (levmar)
[127] that offers interfacing with MATLAB via a binary MEX file. Unlike the
MATLAB implementations of the Levenberg-Marquardt algorithm, levmar
allows for enforcing bound constraints on the fitted variables. An updated
version of the MATLAB processing script was created by implementing the
levmar library and including analytical definitions of the Jacobian functions
(Appendix D). This reduced the computation time to only several minutes per
MESI ICT frame, a marked improvement over the original technique.
While MATLAB offers convenience as a scripting language for editing
and debugging, its computation capabilities pale in comparison to compiled
programs. In order to further increase the processing speed, a standalone
program implementing the levmar package was created in C (i.e. “MESI.c”).
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Table 4.1: Comparison of processing speeds on a 1194 x 994 pixel MESI frame.
Technique Analytical Jacobian Total Time (s) Per Fit (ms) Speedup
MATLAB
Old Script
No 10,944 9.22 -
MATLAB
lsqnonlin()
Yes 2,240 1.89 4.9x
MATLAB
levmar
Yes 262.4 0.22 42x
Compiled
MESI.c
Yes 12.9 0.011 850x
Specifically, the slevmar bc der() function was utilized to perform the fitting
process with single-precision floating-point numbers, box constraints, and an an-
alytical definition of the Jacobian. The program directly reads speckle contrast
data files from the Speckle Software and outputs the four fitted variables into
a similarly structured file. This compiled program reduced computation time
to only tens of seconds per MESI ICT frame. While insufficient for real-time
processing on full-size images, downsampling data in the Speckle Software
could allow for near real-time views of MESI ICT.
An overview of the processing speeds for each of the previously mentioned
fitting techniques is shown in Table 4.1. Benchmarks were performed using
MATLAB R2017a on a desktop computer with an overclocked (4.2 GHz) Intel
Core i5-4690K processor and 32 GB of memory (1866 MHz DDR3). The
MATLAB scripts were parallelized using the Parallel Computing Toolbox to
create four local workers while the MESI.c program spawned four threads to
perform the fitting in parallel. A total of 1,186,836 individual fits had to be
performed for the 1194 x 994 pixel MESI frame. The boundary conditions,
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Figure 4.5: Comparison of MESI parameter fitting performance for the old
MATLAB processing script and the new compiled MESI.c program. ROIs
covering vasculature (purple), parenchyma (green), and static skull (orange)
were examined. (MSE = Mean Squared Error).
initial parameter guesses, and maximum number of iterations (n = 1000)
were held consistent across all four tests. Implementing the levmar package in
MATLAB and C offered significant improvements in processing speed compared
to the native MATLAB fitting functions.
Figure 4.5 depicts the resulting fitting performance for the standalone
program compared to the original processing script across vascular, parenchyma,
and static regions. While there were minimal differences between the mean
squared errors of each fit to the original data, the Levenberg-Marquardt algo-
rithm more closely followed the vascular data at longer exposure times compared
to the Trust-Region-Reflective algorithm. Regardless of the discrepancies, the
enormous increase in computation speed afforded by the MESI.c program
makes it the only viable option for large-scale MESI dataset processing.
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4.3 In Vivo Demonstration of MESI
The upgraded system was tested in vivo with anesthetized mice to
demonstrate the MESI technique. Figure 4.6A depicts the 15 speckle contrast
images composing a single MESI frame, each acquired with different exposure
times. The shorter exposures only reveal the greater flow of the large central
vein while the longer exposures show increasing vascular detail. This highlights
the sensitivity of an exposure time to only certain ranges of particle speeds
and why multiple exposures covering a broad range of values are necessary to
more robustly estimate τc.
Figure 4.6B depicts the resulting MESI ICT image calculated from
the set of speckle contrast images using the process described in Section 4.2.
Because of the large range of τc values, ICT images are typically displayed using
a logarithmic scale. This image represents the best estimate of τc currently
possible using the LSCI technique. Figure 4.6C plots the speckle variance (K2)
of the highlighted vascular and parenchyma regions and their corresponding
fits to Equation 4.1. As τc decreases with increased scattering particle speed,
the speckle variance curve shifts towards the left. It is important to sample
as much of this curve as possible in order to properly estimate the particle
dynamics. The measurements within the vessel would likely benefit from the
addition of shorter exposure times since only four exposures (50, 75, 100, 250
µs) capture the linear portion of the curve.
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Figure 4.6: (A) Speckle contrast images from the mouse cortex for each of
the 15 MESI exposures and (B) the resulting ICT image. (C) Fitted speckle
variance (K2) curves from the vascular (blue) and parenchyma (orange) regions
outlined in B (Scale bars = 1 mm).
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4.4 Sensitivity and Reproducibility of MESI
Microfluidic devices have been used extensively to characterize both
LSCI and MESI because they offer controlled testing environments with precise
regulation of flow rates [71, 64, 38]. While syringe pumps are broadly utilized,
they are prone to unwanted oscillations and frequently exhibit slow responsivity
to flow changes [128, 129, 130]. Pressure-based flow regulation systems overcome
the traditional mechanical limitations of syringe pumps by using air pressure
to push fluids at a constant flow rate. Coupled with inline measurements of
absolute flow for feedback, these systems allow for users to directly program
complex flow profiles.
4.4.1 Standalone MESI Instrumentation
The microfluidic tests were performed on a standalone MESI system
(Figure 4.7) that features similar instrumentation to the previously described
dual-modality imaging system. A 785 nm wavelength-stabilized laser diode (300
mW, LD785-SEV300, Thorlabs, Inc.) was mounted in a temperature-controlled
housing (TCLDM9, Thorlabs, Inc.) and collimated using an aspheric lens
(C280TMD-B, Thorlabs, Inc.). The operating current was set to 380 mA using
a laser diode controller (LDC205C, Thorlabs, Inc.) and the diode temperature
set to 25 ◦C using a temperature controller (TED200C, Thorlabs, Inc.). The
collimated laser light was passed through a free space optical isolator (Electro-
Optics Technology, Inc.) to minimize back reflections that interfere with single
frequency performance. Because the external volume holographic grating of the
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Figure 4.7: Schematic of the standalone MESI system used for microfluidic
testing.
stabilized laser diode produces a dark spot in the far field, the laser was coupled
into a single mode patch cable (125 µm cladding, P3-780A-FC-2, Thorlabs, Inc.)
to obtain a Gaussian beam. The fiber output was re-collimated (F230APC-780,
Thorlabs, Inc.) and modulated using a 100 MHz AOM (3100-125 AOM +
1110AF-AIFO-1.0 RF Driver, Gooch & Housego) with the first order diffraction
isolated and relayed to obliquely illuminate the sample. A pair of camera
lenses were used to image the scattered light (AF Nikkor 50mm f/1.8D + AF
Micro-Nikkor 105mm f/2.8D, Nikon Corp.) with 2.1x magnification through a
bandpass filter (785±31 nm, 87-773, Edmund Optics Inc.) to a CMOS camera
(acA1920-155um, 1920 x 1200 pixels, Basler AG). Only a subset of the overall
sensor array was used (1000 x 750 pixels), resulting in a FOV of 2.9 x 2.2 mm.
A multifunction I/O device (USB-6363, National Instruments Corp.) was used
to produce the camera exposure trigger signals and AOM modulation voltages.
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4.4.2 Microfluidic Device
The microfluidic device utilized for testing MESI featured a single 300 x
300 µm cross-sectional channel and was fabricated from polydimethylsiloxane
(PDMS). 1.8 mg of titanium dioxide (TiO2) was added per gram of PDMS to
produce background scattering properties (µs’ = 8 cm
−1)[71] similar to that
of extravascular brain tissue for visible-NIR wavelengths of light [131]. The
complete manufacturing process can be found in [96].
In order to measure the flow rate through the phantom, a mass flow
sensor (Flow Sensor L, Fluigent Inc.) was placed in-line between the pressure-
based flow control system and the inlet of the microfluidic device. The sensor
was connected to a proprietary hub (FlowBoard, Fluigent Inc.) and the
accompanying software (MAESFLO, Fluigent Inc.) used to record the absolute
flow rate. The pressure control system (MFCS-EZ, Fluigent Inc.) was connected
to the house air line via a 500 mbar regulator and a 15 mL pressurized reservoir
(Fluiwell-1C, Fluigent Inc.) filled with the liquid used in the microfluidic. The
flow rate control software was used to adjust air pressure to the reservoir in
order to achieve the desired flow rate as measured with the flow sensor. This
feedback mechanism allows the flow system to compensate for deviations caused
by particle aggregation or air bubbles.
A suspension of 1 µm diameter polystyrene microspheres (5100A, Thermo
Fisher Scientific) in ultra-filtered deionized water was utilized as a blood-
mimicking sample. The microsphere concentration was selected to match to the
scattering coefficient of whole blood (µs = 243 cm
−1) assuming a 50% hemat-
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Figure 4.8: (A) Speckle contrast image of the 300 µm microfluidic channel
(Scale bar = 1 mm). The highlighted ROI is used for all subsequent flow
analyses. (B) Programmed flow profile measured using the inline flow sensor
with flow rates stepped between 1-10 mm/s.
ocrit and SO2 > 98% [131]. Prior to a microfluidic experiment, the solution
was sonicated in a glass vial to fully suspend the particles and degassed under
vacuum to remove any bubbles that could disrupt stable flow. Figure 4.8A
depicts a 5 ms LSCI frame of the 300 µm microfluidic channel with a flow rate
of 10 mm/s. The highlighted ROI was used for all MESI ICT measurements.
Figure 4.8B depicts the stepped flow profile utilized in all the microfluidic
experiments measured using the inline flow sensor. The flow rate was increased
from 1-10 mm/s in 0.5 mm/s increments over the course of 40 minutes. This
range of flow rates was selected based on prior measurements of red blood cell
velocities in rodent microvasculature [132].
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4.4.3 Microfluidic Measurements with MESI
MESI was used to continuously image the microfluidic channel over
the duration of the 40-minute stepped flow profile with an acquisition rate of
approximately 1.5 fps. The average speckle contrast was computed at each
timepoint within the ROI highlighted in Figure 4.8A. Because β is theoretically
a constant that only depends upon experimental conditions, it was estimated
by performing an initial fit of the median of the data to Equation 4.1. The full
multi-exposure speckle contrast timecourse was then fit to the same equation
while holding β constant at the estimated value. A moving average filter (n =
5) was applied to the resulting τc timecourse.
In order to compare the fitted values of τc to the absolute measurements
from the flow sensor, the relative values of both measurements were computed
using the 10 mm/s flow step as the baseline (Figure 4.9A). The MESI rICT
measurements closely mirror the flow sensor measurements with increased
deviation at the slower flow rates and greater fluctuations over the entire
flow profile. The measured speckle variance (K2) and resulting MESI fits for
each integer flow rate can be seen in Figure 4.9B. The relationship between
increasing flow rates and τc can be seen as the curves shift towards the left.
Because β was held constant, all the curves are converging to the same value
(0.1430) as the exposure time approaches zero. However, this can negatively
impact the quality of the resulting fits, as seen with the 1 mm/s curve, which
deviates from the measured speckle variance at the shorter exposure times.
The same measurements were conducted across multiple trials to exam-
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Figure 4.9: (A) Performance of MESI relative flow estimates compared to the
flow sensor. Both measurements were normalized against the final 10 mm/s
flow step. (B) Speckle variance curves and MESI fits from each flow step
highlighting the relationship between flow rate and τc.
ine the reproducibility of the MESI estimates of ICT (Figure 4.10A). Runs 1
and 2 produced almost identical plots while Runs 3 and 4 appear to deviate at
flow rates >5 mm/s. However, plotting the average ICT against the average
flow sensor measurements during each step (Figure 4.10B) reveals that the
flow system overshot the requested values during Runs 3 and 4. Therefore
the apparent deviations in ICT seen in Figure 4.10A were actually caused by
the flow rate being higher during those two runs. These results indicate that
MESI can provide stable day-to-day estimates of τc across a broad range of
flow rates, thereby allowing the parameter to serve as a reliable baseline value
for chronic or multiple-animal studies. The strong linear relationship between
ICT and absolute flow rate suggests that calibrated measurements could be
possible under ideal conditions.
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Figure 4.10: (A) Consistency of MESI ICT measurements across multiple
trials. (B) MESI underestimates ICT at higher flow rates resulting in a slight
divergence from unity. Error bars (s.d.) are displayed but smaller than the
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4.5 Discussion
The MESI technique allows for more robust estimates of τc compared
to traditional single-exposure LSCI [71]. The improved mathematical model
properly accounts for the presence of static scatterers in a sample and the
multiple exposure times sample a broader range of flow rates. The implemen-
tation of MESI in the dual-modality imaging system facilitates more reliable
measurements of flow deficits during targeted photothrombotic stroke [110] and
improves the quantitative accuracy of chronic CBF measurements [123]. The
upgraded system was demonstrated in vivo by imaging the cortical vasculature
of a mouse and examining the quality of the resulting MESI ICT imagery.
The modifications made to the Speckle Software, optimization of the
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calibration procedure, and improvements in processing speed have simplified
the use of the MESI technique. Because the MATLAB script controlling
the camera exposure trigger signals and AOM modulation voltages currently
utilizes the ANSI C NI-DAQmx library, integrating the entire MESI calibra-
tion and acquisition process into the Speckle Software should be relatively
straightforward. The >800x improvement in processing speed achieved with the
compiled fitting program facilitates the full-frame analysis of MESI data that
was previously impractical because of computation time. While still insufficient
for the real-time processing of full-resolution speckle imagery, downsampling
by a factor of two could allow for near 1 fps views of MESI-estimated ICT in
the Speckle Software.
The microfluidic measurements conducted on the standalone MESI
system further demonstrate the robustness of the technique for estimating
τc. The linear relationship between ICT and absolute flow rate highlights the
broad range of flows that can be properly measured by MESI. The day-to-
day stability of ICT will allow the metric to serve as a reliable baseline for
chronic or multiple-animal studies. While the standalone system utilized an
expensive wavelength-stabilized laser diode, any day-to-day fluctuations should
be accounted for by the β parameter in Equation 4.1 as long as the laser is not
mode hopping. The optimization of the LSCI laser diode in the dual-modality
system (Section 2.1.5) indicated stable speckle contrast measurements over
time.
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Chapter 5
Chronic Awake Imaging of Photothrombotic
Stroke
Anesthesia is widely used in preclinical neuroscience research to sedate
animals while imaging despite systemic effects on neuronal and vascular function
[133]. The volatile anesthetic isoflurane has been shown to reduce excitatory
synaptic transmission [134], impair oxygen autoregulation [135], suppress the
magnitude and speed of neurovascular coupling [136], and cause abnormal
increases in CBF [137, 138]. Isoflurane has also been shown to convey neuro-
protective effects that may reduce the severity of ischemic lesions [139, 140]
and suppress the occurrence and frequency of spreading depolarizations [141].
These effects can mask the benefits of neuroprotective agents and potentially
impact the outcomes of long-term studies [142, 143]. Our lab has reported
[88, 82, 91] conflicting vascular pO2 measurements that can likely be attributed
to the use of different general anesthetics (urethane vs. isoflurane).
The elimination of anesthesia from neuroimaging experiments has grown
increasingly popular in recent years with two primary strategies taking the
forefront. The first is the usage of head-mounted microscopes that minia-
turize many of the optical components into a package that can be installed
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on the head of the subject [144, 145, 146]. While this technique allows for
freely-moving tethered imaging, it requires extensive optical engineering and
introduces significant motion artifacts caused by normal animal behavior [145].
Miniaturizing the system described in this dissertation would require significant
sacrifices in spatial and temporal resolutions for both imaging modalities.
The second strategy involves restraining the animal’s head while posi-
tioned on a rotating treadmill [136, 147, 148, 149, 150] or confined in a small
chamber [151], which permits the use of existing imaging platforms. This
technique allows for walking or running in place while minimizing motion of
the head and imaging region. A spherical treadmill design has been used
to perform awake two-photon microscopy with only an estimated 2-5 µm of
lateral motion [147], which is near the resolution of the dual-modality imaging
system. This chapter details the transition from anesthetized to awake animal
imaging, including the selection of a treadmill-based restraint system and in
vivo demonstrations of chronic awake imaging.
5.1 Awake Imaging System Design
The spherical treadmill described by Dombeck et al. [147] is a popular
design in the neuroscience community. It features a large (8-inch) Styrofoam
ball supported on an air cushion produced by a perforated hemispheric casting.
The ball allows for two dimensions of free movement, which reduces the torque
the animal can apply to its permanently-attached metal headbar that encircles
the cranial window. An implementation of this design using a 3D-printed base
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can be seen in Figure 5.1A. A series of channels spanning the plastic cylinder
direct the flow of air upwards to form the supporting air cushion. Flow is
regulated using the standard house air supply and can be adjusted as needed
depending on the weight of the ball and the subject. While preliminary tests
showed the design was functional, the loudness of the flowing air was deemed
unsuitable for practical use. The height of the entire apparatus was also a
major limitation, with only the dual-modality imaging system capable of the
necessary vertical translation.
Two alternative designs with lower profiles were examined. The first
implemented (Figure 5.1B) a rotating foam wheel [150] that allowed for one
dimension of free movement. The coarse surface of the foam appeared to offer
a better grip for the animal than the Styrofoam ball, making it easier to walk.
While the vertical height was still substantially greater than the stereotaxic
frame used during anesthetized imaging, the apparatus could easily fit under
both the dual-modality and standalone MESI systems. However, issues were
encountered with the stability of the rotation caused by difficulties in precisely
centering the axle through the foam. These rotational variations in the position
of the surface of the wheel relative to the headbar caused large motion artifacts
in the resulting speckle contrast imagery despite head fixation.
The second design implemented (Figure 5.1C) a continuous belt treadmill
[152, 149] that also allowed for one dimension of self-propelled movement. The
rubberized tread rotated over two pulleys made from LEGO tires and axles
(Figure 5.1D-E) with the animal centered over a flat piece of plastic. This
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Figure 5.1: (A) Air-cushioned spherical treadmill, (B) foam wheel treadmill,
and (C) low-profile continuous belt treadmill. Close-up of the (D) front and
(E) rear pulley wheels on the belt treadmill. (F) Mouse head-restrained on
the belt treadmill using the permanently attached headbar.
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eliminated the vertical variations that negatively impacted the wheel-based
design and resulted in more stable LSCI measurements when the animal moved.
The height of the treadmill was also further reduced and only slightly taller than
the conventional stereotaxic frame. Figure 5.1F depicts a mouse restrained on
the treadmill system via its permanently attached metal headbar (see Appendix
C.2).
5.2 Effects of Anesthesia on Hemodynamics
In vivo imaging with the head-restrained treadmill system was demon-
strated by comparing awake and anesthetized hemodynamics. The subject
was mounted on the treadmill using its headbar and allowed to acclimate for
10-15 minutes prior to imaging. The mounting rods were adjusted as necessary
to maintain a comfortable head position and to orient the cranial window
perpendicularly to the optical axis. Subjects quickly adapted to walking on
the treadmill and would exhibit regularly grooming behavior when stationary.
5.2.1 Dynamic Cerebral Blood Flow
An extended MESI acquisition was performed on the standalone MESI
system to monitor the stability of awake and anesthetized measurements and the
transition between the two states. The awake subject was imaged continuously
for one hour with a nose-cone placed directly in front of the restrained animal
and delivering only medical air. General anesthesia was then quickly induced
with medical air vaporized isoflurane (2.5%) via the nose-cone. After several
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Figure 5.2: Speckle contrast (top) and MESI ICT (bottom) imagery from a
mouse while awake (left) and anesthetized (right) exhibits the systemic change
in CBF (Scale bar = 1 mm).
minutes, the isoflurane was reduced to 1.5% and a feedback heating pad (DC
Temperature Controller, FHC) placed under the animal to regulate body
temperature. The anesthetized subject was imaged for an additional one hour
before being removed from anesthesia and allowed to recover on the heating
pad.
Figure 5.2 depicts averaged single-exposure (5 ms) speckle contrast
images and their corresponding MESI ICT images during the awake and anes-
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thetized states. Anesthesia caused a systematic increase in CBF as exhibited
by the decrease in average speckle contrast (0.199 → 0.166) and increase in
average ICT (2798 s−1 → 6579 s−1). Significant vasodilation can also be seen
in the large central vein and the many smaller vessels that only become visible
in the anesthetized state. These results are consistent with volatile anesthetics
being potent vasodilators that cause dose-dependent increases in baseline CBF
uncoupled from local metabolic demands [153].
Figure 5.3A highlights two vascular regions (R1, R2) and one parenchyma
region (R3) analyzed over the entire awake-to-anesthetized MESI acquisition.
While the head-restraint minimized most undesired motion, elastix was used
during post-processing to rigidly align all speckle contrast frames to the begin-
ning of the acquisition. Figure 5.3B depicts the resulting relative blood flow
timecourses using the average of the entire one hour of awake imaging as the
ICT baseline. Flow was stable throughout the awake imaging segment with
occasional spikes corresponding to animal motion. However, it is difficult to
determine whether these are real changes in blood flow or if the physical motion
itself is causing the change in τc. The induction of general anesthesia rapidly
caused a 3x increase in relative flow across all three ROIs before reaching a
semi-stable state after about 10 minutes. The spike around t = 5000 seconds
was likely caused by an unstable anesthesia plane or difficulty with breathing
resulting in increased animal motion. However, this quickly subsided and the
flow remained relatively stable as it slightly declined to around 2.5x of baseline
in all three ROIs over the remainder of the imaging session.
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Figure 5.3: (A) MESI ICT was calculated within two branches of a large
central vein (R1 and R2) and a parenchyma region (R3) as a mouse was
anesthetized (Scale bar = 1 mm). (B) Relative ICT timecourses over one
hour of awake imaging followed by one hour of anesthetized imaging. (C)
Estimated diameters of R1 and R2 over the imaging session. (D) Relative ICT
timecourses using the multiple dynamic scattering MESI model.
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In order to examine anesthesia-induced vasodilation, the diameters of
both vessels (R1, R2) were estimated from the speckle contrast images. Cross-
sectional profiles (the black bars in Figure 5.3A) averaged over the length of
each ROI were fitted to a Gaussian distribution. The vessel diameter was
defined as the full width at half maximum (FWHM) of the fitted cross-section.
The FWHM was computed for both vessels in every frame of the acquired
data and is shown in Figure 5.3C. Similar to the relative flow within the ROIs,
the diameters remained stable throughout the entire awake imaging segment.
However, the induction of anesthesia caused significant vasodilation in vessel R1
(+54%) while vessel R2 increased slightly (+23%) over the entire anesthetized
imaging segment. The reason for this discrepancy is unclear, especially since
the imagery in Figure 5.2 appears to show systemic vasodilation. The use
of speckle contrast images for estimating the vessel diameter is a somewhat
ill-posed problem since the technique has reduced spatial resolution compared
to a conventional reflectance image.
As discussed in Chapter 4, the standard MESI model represented by
Equation 4.1 assumes that detected photons only experience single dynamic
scattering interactions and the underlying particle motion has a Lorentzian
velocity distribution indicative of Brownian motion [71]. However, camera
pixels corresponding to resolvable surface vasculature are more likely to sample
photons that have experienced multiple dynamic scattering events [62] and
exhibit Gaussian velocity distributions indicative of bulk flow [38]. The single
dynamic scattering correlation time (τ sdsc ) can be converted to the multiple
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dynamic scattering correlation time (τmdsc ) by scaling the former by the average
number of dynamic scattering events (Nd), which is proportional to the vessel
diameter [38]. Figure 5.3D plots the “corrected” relative ICTmds that accounts
for multiple scattering events using the vessel width data from Figure 5.3C. This
new estimate shows a slightly reduced 2.5x increase in flow during anesthesia
in the vascular ROIs compared to the 3x increase seen with relative ICTsds.
It also reveals a more substantial decrease in flow over the remainder of the
anesthetized imaging session down to only 1.5x of baseline.
5.2.2 Static Cerebral Blood Flow and Oxygen Tension
MESI and pO2 measurements were performed on the dual-modality
imaging system to examine the behavior of the two hemodynamic parameters
in the awake and anesthetized states. The subject was briefly anesthetized
to administer Oxyphor PtG4 via retro-orbital injection for a target blood
plasma concentration of 5 µM and allowed to recover for two hours before
being placed on the treadmill. Static MESI and 445 nm pO2 measurements
were acquired from the ROIs shown in Figure 5.4A covering one arteriole (A1),
three veins (V1, V2, V3), and one parenchyma region (P1). The subject was
then anesthetized in place via nose cone inhalation of medical air vaporized
isoflurane (1.5%) and another set of MESI and 445 nm pO2 measurements
acquired after 15 minutes.
Figure 5.4B shows the change in MESI ICT within each of the ROIs
between the awake and anesthetized states. Similar to the results shown in
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Figure 5.4: (A) Awake single-exposure speckle contrast image overlaid with
regions targeted for ICT and pO2 measurements (Scale bar = 1 mm). One
arteriole (A1), three veins (V1, V2, V3), and one parenchyma region (P1) were
examined. The ROIs covered areas between 0.028-0.039 mm2. (B) MESI ICT
and (C) 445 nm pO2 measurements within the targeted regions during awake
and anesthetized states (mean ± s.d.).
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Section 5.2.1, there was a 2.5x increase in relative flow while under general
anesthesia. The pO2 measurements also experienced a systematic increase
when in the anesthetized state (Figure 5.4C). The awake pO2 is significantly
lower than the values reported in Section 2.3 and the arteriole only exhibits a
marginally higher pO2 compared to the other regions. These results are similar
to the findings of Lyons et al. [154], who reported a mean capillary pO2 of 36
mmHg in the cortex and suggested that the increase in pO2 during anesthesia
is caused by the increase in blood flow.
5.3 Awake Targeted Photothrombosis Induction
Targeted photothrombosis was demonstrated in an awake mouse while
simultaneously monitoring CBF and pO2 (Figure 5.5). The subject was briefly
anesthetized on the treadmill via nose-cone inhalation of isoflurane (3.0%) in
order to administer rose bengal (50 µL, 15 mg/mL) via retro-orbital injec-
tion. Anesthesia was immediately stopped and the nose-cone removed, with
the animal regaining consciousness after about three minutes. A descending
arteriole (Figure 5.5A) was targeted at t = 90 seconds with DMD-patterned
green light for 10 minutes to induce a photothrombotic occlusion. 445 nm
pO2 measurements were continuously acquired from the stroke target region
at 1 Hz with 2500 decays averaged per record. The series of speckle contrast
images depict the progression of photothrombosis with the targeted vessel
fully occluding after less than three minutes of exposure. elastix was again
used during post-processing to rigidly align all speckle contrast frames to the
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beginning of the acquisition.
Figure 5.5B depicts the five regions (one arteriole, three veins, and one
parenchyma) monitored for dynamic relative blood flow and pO2 measurements.
The arteriole region (A1) is the same vessel targeted for photothrombotic
occlusion. ROI pO2 measurements were initiated shortly after the end of
photothrombosis irradiation with patterns displayed at 2 Hz with 1250 decays
averaged per record. The resulting timecourses of relative blood flow and pO2
can be seen in Figure 5.5C. Compared to the anesthetized photothrombosis
measurements in Section 3.2, these timecourses are significantly more variable
because of walking and other animal motions. However, the subject had no
visible reaction to the photothrombosis. By t = 200 seconds, flow within the
targeted arteriole had decreased to <50% of baseline and pO2 had dropped
from 60 mmHg to around 30 mmHg. However, the animal was likely still
experiencing the effects of anesthesia, making it impossible to attribute the
changes exclusively to the photothrombotic occlusion.
The propagation of an ischemia-induced depolarization event can be
seen beginning at t = 1150 seconds, with sharp reductions in both relative blood
flow and pO2 across all ROIs. The magnitude of these changes are smaller than
those seen in the anesthetized data (Figure 3.2C), which is consistent with the
results of a calcium imaging study performed during awake ischemic stroke
[155]. As the depolarization subsided, flow within the targeted arteriole further
decreased to <20% of baseline while the pO2 dropped to only 10 mmHg. Flow
and pO2 in all other regions remained depressed following the depolarization
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Figure 5.5: (A) Single-exposure speckle contrast images depicting the occlusion
of a descending arteriole using DMD-targeted photothrombosis. The red overlay
indicates the 0.06 mm2 region simultaneously illuminated for occlusion and
pO2 measurements. (B) One arteriole (A1), three veins (V1, V2, V3), and
one parenchyma region (P1) were targeted for pO2 measurements after stroke
induction. (C) Relative blood flow and pO2 within the targeted regions during
and after photothrombosis. The green-shaded section indicates irradiation of
the targeted arteriole. The gap in data occurred because of technical difficulties.
The arrows indicate the propagation of an ischemia-induced depolarization
event (Scale bars = 1 mm).
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and were relatively steady until the end of the 40-minute imaging session.
There was also a reduction in animal motion compared to pre-depolarization
behavior as seen by the lack of regular spikes in relative blood flow.
5.4 Chronic Awake Post-Stroke Hemodynamics
The chronic progression of the ischemic lesion was monitored using awake
imaging for eight days following photothrombosis. Anesthesia was not utilized
in any of the post-photothrombosis imaging sessions. Data was only acquired
when the animal was completely stationary because motion could interfere
with the measurements and the resulting hemodynamic response would not
be indicative of the resting state. The perfusion of the occluded arteriole and
broader effects on cortical flow were tracked using 5 ms single-exposure LSCI
(Figure 5.6A) and MESI ICT (Figure 5.6B). Tiled pO2 maps acquired using
445 nm excitation reveal the spatial extent of the oxygen deficit and subsequent
recovery (Figure 5.6C). The broad range of pO2 values covered by the colormap
masks the smaller differences between arterioles and veins that can be seen on
Day -0. The gradient between the occluded vessel and the surrounding tissue
diminishes over the course of Days +1, +2, and +3 as the occluded arteriole
begins to reperfuse. By Day +5, the vessel had fully reperfused leaving little
evidence of the infarct in the speckle contrast or ICT imagery while the tiled
pO2 maps reveal a region of increased oxygenation surrounding the formerly
occluded vessel. However, the distal pO2 measurements also appear to have
increased, suggesting this change may be systemic.
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Figure 5.6: Progression of the ischemic lesion over eight days as imaged with
(A) single-exposure LSCI, (B) MESI ICT, and (C) 445 nm tiled pO2 measure-
ments. Day -0 measurements were taken immediately prior to photothrombosis
induction and Day +0 measurements were taken immediately after. (D) One
arteriole (A1), three veins (V1), and one parenchyma region (P1) were targeted
for chronic (E) relative blood flow and (F) 445 nm pO2 measurements (mean
± s.d.). Relative MESI ICT was baselined against Day -0 measurements (Scale
bars = 1 mm).
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The same five regions (one arteriole, three veins, and one parenchyma)
used during the acute awake photothrombosis measurements were also targeted
for chronic relative blood flow and 445 nm pO2 measurements (Figure 5.6D-F).
The relative blood flow was calculated using the pre-stroke (Day -0) MESI ICT
measurements as the baseline. The first post-stroke measurements (Day +0)
were taken immediately after the conclusion of the photothrombosis induction
and reveal systemic deficits in both blood flow and pO2 likely caused by the
spreading depolarization. Blood flow within the targeted arteriole (A1) and
a nearby vein (V2) slowly recovered over the course of five days while the
remaining ROIs experienced a slight overshoot in relative flow during the same
period. Flow continued to increase across all ROIs over the remaining three
days and was elevated over baseline by the final imaging session on Day +8.
Similar results are seen in the pO2 measurements, with only A1 experiencing
a significant decline from pre-stroke values and the pO2 increasing across all
ROIs over the eight days of imaging. A1 also exhibits the elevated pO2 seen in
the tiled maps (Figure 5.6C) beginning on Day +5.
The speed of the recovery from the photothrombotic infarct is similar
to the anesthetized results (Section 3.3) and faster than previous studies in the
lab [116]. The targeted arteriole remained occluded for three days following
photothrombosis before fully reperfusing. During this period, another arteriole
approaching from midline (bottom of the camera FOV) hyperperfused and
likely served as a collateral blood supply to mitigate the severity of the flow
deficit. Once flow was restored to the targeted vessel on Day +4, the collateral
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arteriole returned to near baseline flow. Creating a larger infarct would have
required targeted both arterioles with the DMD to more severely reduce flow
to the region.
5.5 Discussion
The transition to fully awake imaging eliminates the systemic effects of
general anesthesia. The potent vasodilation [138] and suppression of neurovas-
cular coupling [136] caused by isoflurane is a significant confounding variable
when studying chronic cortical hemodynamics. The head-restrained treadmill
design using a continuous linear belt allows for awake imaging while minimizing
animal motion that could disrupt the optical measurements. In vivo awake
imaging was demonstrated with the apparatus using both the dual-modality
and standalone MESI systems. Comparisons with anesthetized imaging high-
lighted the systemic effects of isoflurane of cerebral hemodynamics, with both
blood flow and pO2 more than doubling under general anesthesia.
Despite the efficacy of the head restraint system, correlation time esti-
mates with LSCI remain extremely sensitive to any motion within the imaging
area. The animal walking would cause abrupt spikes in ICT that could not
definitively be ascribed to neurovascular coupling instead of just a slight
motion-related displacement. Excluding data during these periods of height-
ened activity offers the simplest solution for acquiring reliable instantaneous
measurements of blood flow. However, if the hemodynamic response itself is
being studied, then further measures would need to be taken in order to more
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robustly restrict motion of the brain.
The induction of a DMD-targeted photothrombotic occlusion produced
similar results to the anesthetized demonstration in Section 3.2. However, the
induction procedure still required the brief use of anesthesia for the injection of
the photothrombotic agent. While it is unclear what minimum dosage of isoflu-
rane is needed to convey its neuroprotective effects [142], the photothrombosis
was performed under the lingering influence of isoflurane. This obfuscates the
true changes in blood flow and pO2 caused by the photothrombotic occlusion
itself. Transitioning to a tail vein or intraperitoneal injection prior to mounting
on the treadmill would allow for the complete elimination of isoflurane from
the stroke induction process.
The resulting infarct was less severe than the anesthetized demonstra-
tion and was likely mitigated by the availability of collateral blood supply.
The timeline for reperfusion of the targeted vessel was similar to that of the
anesthetized chronic imaging (Section 3.3) with a full recovery after five days.
The use of MESI allowed for more robust estimates of τc and therefore more
reliable day-to-day comparisons of blood flow than traditional single-exposure
LSCI. Combined with the absolute measurements of pO2, the dual-modality
imaging system facilitates the chronic study of ischemia in awake animals.
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Chapter 6
Conclusions
Optical imaging technologies have been utilized extensively in preclinical
research to study the complex hemodynamics of the normal and diseased brain.
They offer significant advantages over many other imaging modalities because
of superior spatial and temporal resolutions, the availability of a wide array
of contrast agents, and relatively inexpensive hardware costs. The distinct
wavelengths and spectra of illuminating and detected light readily facilitates the
combination of different imaging modalities. This permits simultaneous multi-
parameter measurements in subjects without requiring repeated trials for each
individual imaging modality and provides a more comprehensive understanding
of cerebral hemodynamics.
This dissertation presented the development of a dual-modality op-
tical imaging platform capable of acute and chronic monitoring of cerebral
hemodynamics during ischemic stroke and the subsequent recovery. The sys-
tem combined laser speckle contrast imaging (LSCI) with oxygen-dependent
quenching of phosphorescence to measure relative blood flow and oxygen ten-
sion within cortical vasculature with high spatial and temporal resolutions. A
digital micromirror device (DMD) was used to spatially-pattern phosphorescent
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excitation light to overcome traditional limitations of the imaging technique.
The DMD was also utilized to perform spatially-targeted photothrombosis
within pial arterioles for the induction of highly-localized ischemic lesions. The
capabilities of the imaging system were demonstrated by monitoring the acute
hemodynamic response during targeted photothrombosis and the chronic re-
covery of the resulting infarct. The LSCI hardware and software was upgraded
to perform multi-exposure speckle imaging (MESI) in order to produce more
quantitatively accurate estimates of blood flow via the improved physical model.
The transition to fully awake imaging using a head-restrained treadmill elimi-
nated the confounding effects of anesthesia upon cerebral hemodynamics. The
capabilities of the complete awake imaging system were again demonstrated by
monitoring the acute and chronic response to targeted photothrombosis.
6.1 Future Work
While the dual-modality imaging system is functionally complete, there
are numerous improvements that could be made to the instrumentation and
acquisition control software. MESI is currently performed using a standalone
MATLAB script running in parallel with the Speckle Software, which only con-
trols the camera. Integrating the generation of the necessary trigger/modulation
waveforms and the calibration procedure directly into the Speckle Software
would greatly simplify MESI acquisitions and facilitate distribution to other
researchers. This would also permit for streamlining the signal generation
and acquisition of the phosphorescence lifetime measurements so that they are
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properly interleaved between MESI illumination pulses to minimize crosstalk
between the two imaging modalities.
The impact of camera bit depth on the accuracy of MESI estimates of
τc have yet to be quantified. Comparisons between 8-bit and 16-bit cameras
using traditional single-exposure LSCI found minimal differences in relative
flow accuracy [64, 96] despite the increased sensitivity and dynamic range
offered by more expensive cameras. Higher frame rates were found to be more
important than bit depth because they allowed for greater temporal averaging.
However, because complete MESI frames are generated much more slowly than
a single-exposure LSCI frame, it is possible the technique could benefit from
the increased sensitivity of a 12- or 16-bit camera.
The current spectral separation of the imaging system offers opportuni-
ties for integrating other optical imaging techniques that utilize wavelengths
between 475-600 nm. Multispectral reflectance imaging at those wavelengths
would allow for detecting relative changes in oxy- and deoxyhemoglobin based
on differences in absorption. This information can be used in conjunction with
LSCI measurements of blood flow to estimate the cerebral metabolic rate of
oxygen consumption (CMRO2), which is widely used in neurovascular studies
[37]. The dual-modality imaging system has already been demonstrated while
simultaneously performing spatially resolved electrical recordings of neural ac-
tivity during and following targeted photothrombosis [156]. Another potential
application of the DMD could be spatially-patterning LSCI illumination light
to reconstruct 3D tomographic measurements of flow from the imaged speckle
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dynamics [157].
This dissertation focused primarily on the development of the hardware
for the imaging system and not the underlying neuroscience it is capable of
probing. There are numerous phenomenon that could be studied using the
simultaneous measurements of blood flow and pO2 or the targeted photothrom-
botic model of ischemic stroke. Establishing robust baseline measurements
of both parameters across various vessels and multiple animals would help
facilitate acute and chronic hemodynamic imaging. Because anesthesia has
been shown to suppress and delay neurovascular coupling [136], there is an
opportunity to reexamine the metabolic and hemodynamic changes associated
with functional activation [54] in awake subjects. Anesthesia has also been
shown to suppress the occurrence of ischemia-induced spreading depolarizations
[141], which have been implicated in expanding the size of the ischemic core
[53]. Awake imaging with MESI would allow for more accurate measurements
of ischemic flow deficits and permit a more robust multi-animal study of this
phenomenon. Combining the quantitative imaging of hemodynamics with
measurements of functional impairment would allow for more reliably testing
the efficacy of acute pharmaceutical interventions and rehabilitation.
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Appendix A
Derivation of the Stern-Volmer Relationship
Upon absorption of radiation, a phosphorescent molecule is excited
(Figure 1.2A) from its singlet ground state (S0) to an excited singlet state (S1)
while maintaining the pairing of its electron spins. The excited singlet state
can then non-radiatively transition to an excited triplet state (T1) through
a process known as intersystem crossing. This results in the unpairing of its
ground and excited state electron spins.
The excited triplet state molecule can return back to its singlet ground
state through either radiative or non-radiative relaxation. The radiative re-
laxation from the excited triplet state to the singlet ground state is known
as phosphorescence and occurs with a decay rate kr. Non-radiative relax-
ation occurs through intersystem crossing at a decay rate kn−r. Collision with
ground triplet state molecular oxygen (3O2) can quench the excited triplet state
molecule back to its singlet ground state while producing excited singlet state
oxygen (1O2). This transfer of electronic excitation energy can be modeled
as a first order reaction with a decay rate proportional to the product of the
quenching constant (kq) and the concentration of dissolved oxygen ([O2]). The
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overall rate equation can be expressed as:
d[P ∗]
dt
= −(kr + kn−r + kq[O2])[P ∗] (A.1)
where [P ∗] denotes the number of excited triplet state molecules. Assuming
that [O2] >> [P
∗], then the rate equation can be integrated to:
[P ∗] = −[P ∗]0e−(kr+kn−r+kq [O2])t (A.2)
The lifetime in the presence of the quencher (τ) can then be defined by inversion
of the overall decay rate:
τ =
1
kr + kn−r + kq[O2]
(A.3)
In the absence of the quencher ([O2] = 0), the lifetime can be simplified to:
τ0 =
1
kr + kn−r
(A.4)
and used to normalize the lifetime in the presence of the quencher:
τ0
τ
=
kr + kn−r + kq[O2]
kr + kn−r
(A.5)
This can be simplified to a linear expression known as the Stern-Volmer
Relationship:
τ0
τ
= 1 + kqτ0[O2] (A.6)
Using Henry’s Law for dissolved gases, pO2 = KH [O2], the molecular oxygen
concentration [O2] can be exchanged for the partial pressure of oxygen (pO2):
τ0
τ
= 1 + kqτ0[pO2] (A.7)
Lifetime can be calibrated against a standard that quantifies either the [O2]
or pO2 in a solution that matches the pH, atmospheric pressure, temperature,
and salinity of the desired sample environment.
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Appendix B
Accessing the DMD on the DLP®
LightCrafter™
The Texas Instruments DLP® LightCrafter™ evaluation module contains
a DLP3000 DMD, a DM365 embedded processor running Linux, and an RGB
LED light engine developed by Young Optics (Figure B.1). In order to utilize
a custom light source such as a laser, the light engine must be removed to
gain physical access to the DMD. The following series of figures details the
disassembly process necessary to access and remount the DMD for use with
custom illumination.
Remove the four screws (Phillips head) on the top of device and detach
the upper circuit board from the lower half of the device (Figure B.2). Turn
Light Engine
DMD
Embedded
Processor
Digital Media
Processor
Figure B.1: Overview of the Texas Instruments DLP® LightCrafter™.
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Figure B.2: Detach the upper circuit board from the device.
the device upside down and remove the four screws (Phillips head) attaching
the light engine to the baseplate from the bottom (Figure B.3). Flip the device
back over and remove the three screws (Phillips head) attaching the light engine
from the top. Remove the two screws (Phillips head) horizontally securing the
light engine to the circuit board (Figure B.4). Use a flat-head screwdriver to
flip the locking clips on the two ribbon cables connecting the light engine to
the circuit board and disconnect the cables.
At this point, the only physical connection remaining between the light
engine and the rest of the device is through the DMD mounting socket. Remove
the entire light engine by pulling horizontally and slightly upwards to disconnect
the DMD (Figure B.5). Remove the two screws (Phillips head) on the plate
119
Figure B.3: Remove the screws attaching the light engine to the baseplate.
Figure B.4: Remove the screws and ribbon cables connecting the light engine
to the circuit board.
120
DMD
Figure B.5: Disconnect the light engine from the board.
DMD
Figure B.6: Extract the DMD from the light engine.
securing the DMD in the light engine (Figure B.6). Remove the metal plate
and extract the DMD chip.
In order to improve physical access to the DMD, the bottom board
can be reoriented on the baseplate. Remove the four standoff screws and
rotate the bottom board by 180◦ so that the DMD mounting socket is facing
outwards (Figure B.7). Any modifications to the baseplate (e.g. drilling
holes for mounting) should be performed at this stage since all electronics are
currently detached. Reattach the bottom circuit board to the baseplate using
the standoff screws and reconnect the DMD to its mounting socket. The notch,
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Figure B.7: Rotate the bottom circuit board by 180◦, reconnect the DMD to
its socket, and reattach the upper circuit board.
which indicates the illumination orientation, should be facing towards the right.
Reattach the top circuit board and secure with the four screws removed at the
beginning.
The LightCrafter™ is now configured for use with custom illumination
paradigms such as the one described in this dissertation. Because the DMD is
now exposed on the edge, care should be taken to avoid physical contact that
might damage the device.
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Appendix C
Sterile Cranial Window Surgical Preparation
While the optical imaging techniques described in this dissertation are
non-contact, a chronic cranial window implantation is required to obtain optical
access to brain tissue. This appendix details the craniotomy procedure and
maintenance protocol utilized for chronic in vivo awake imaging in mice. All
animal protocols were approved by the Institutional Animal Care and Use
Committee at The University of Texas at Austin.
C.1 Implantation of Cranial Window
Mice (CD-1, male, 25-30 g, Charles River) were anesthetized with medi-
cal air vaporized isoflurane (2.0%) via nose-cone inhalation. Body temperature
was maintained at 37 ◦C with a feedback heating pad (DC Temperature Con-
troller, FHC). Arterial oxygen saturation, heart rate, and breath rate were
monitored via pulse oximetry (MouseOx, Starr Life Sciences). After induction,
mice were placed supine in a head-fixed stereotaxic frame (Narishige Scientific
Instrument Lab) and administered carprofen (5 mg/kg, subcutaneous) for
anti-inflammation and dexamethasone (2 mg/kg, intramuscular) to reduce the
severity of cerebral edema following removal of the skull. Surgical instruments
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and artificial cerebrospinal fluid (ACSF, buffered pH 7.4) used during the
craniotomy procedure were sterilized in an autoclave.
The scalp was shaved and resected to expose skull between the bregma
and lambda cranial coordinates. A thin layer of cyanoacrylate (Vetbond Tissue
Adhesive, 3M) was applied to the exposed skull to facilitate the adhesion of
dental cement during a later step. A 2-3 mm diameter portion of the skull over
the frontoparietal cortex was removed while leaving the dura intact using a
dental drill (0.8 mm burr, Ideal Microdrill, Fine Science Tools) with regular
ACSF perfusion to prevent overheating. A 5 mm round cover glass (#1.5, World
Precision Instruments) was placed over the exposed brain and a dental cement
mixture was deposited along the perimeter while applying gentle pressure
to the cover glass. This process bonded the cover glass to the surrounding
skull to create a sterile, air-tight seal around the craniotomy and allowed for
restoration of intracranial pressure. A second layer of cyanoacrylate was applied
over the dental cement to further seal the cranial window. The medial and
anterior edges of the window were approximately 2 mm rostral from bregma
and 0.5 mm lateral from the sagittal suture (Figure C.1). Animals were allowed
to recover from anesthesia and monitored for cranial window integrity and
normal behavior for at least two weeks prior to imaging. Additional carprofen
injections (5 mg/kg) were administered subcutaneously two, four, and seven
days post-surgery to relieve inflammation from the procedure.
124
Bregma
Sagittal Suture
Cranial Window
Lambda
Coronal Suture
Lambdoid Suture
A B
Figure C.1: (A) Location of the cranial window relative to bregma. Skull
illustratrion adapted from [158]. (B) Photograph of a typical cranial window
implantation.
C.2 Headbar Attachment
Animals designated for awake imaging underwent an additional proce-
dure during the application of dental cement to permanently attach a metal
headbar used for head fixation. The circular cutout in the headbar was aligned
with the cranial window and rotated laterally until parallel with the cover glass.
This ensured that the cranial window would be perpendicular to the imaging
system’s optical axis when the animal was restrained in the awake imaging
setup. Dental cement was applied around the headbar to permanently attach
it to the animal’s skull.
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C.3 Chronic Animal Maintenance
Animals were checked daily to monitor both behavior and the integrity
of the cranial window by veterinary staff at the University of Texas at Austin
Animal Research Center (ARC). Animals were housed in climate-controlled
rooms with timed lighting (12-hour light/dark cycles) to maintain a comfortable
living environment and given food and water ad libitum. Social housing with
multiple animals reduced the risk of overeating commonly seen when solo
housing animals. This minimized possible growth in the animal’s size and
helped maintain the integrity of the cranial window. Any aggression resulted
in the removal of the aggressor into a separate cage.
After several weeks of recovery, animals were used for both acute and
chronic imaging experiments. Cranial windows were lightly cleaned prior to
each imaging session using a cotton swab and 70% ethanol (v/v). If necessary,
a topical application of mineral oil was used to improve image quality by index
matching. Any discoloration on or around the cranial window was documented
and monitored for possible infection. Any cracks in or breaking of the cranial
window were also documented and resulted in the immediate euthanasia of the
animal.
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Appendix D
Jacobian Matrix of the MESI Equation
The Jacobian matrix (J) is the matrix of all first-order partial derivatives
of a vector-valued function (f):
J =
[
∂f
∂x1
. . .
∂f
∂xn
]
=

∂f1
∂x1
. . . ∂f1
∂xn
...
. . .
...
∂fm
∂x1
. . . ∂fm
∂xn
 (D.1)
and can be expressed component-wise as:
Jij =
∂fi
∂xj
(D.2)
The partial derivatives comprising the Jacobian matrix of the MESI equation
(Equation 4.1) for use in the Levenberg-Marquardt optimization algorithm are
as follows:
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